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Abstract 
 
Adherence to self-management strategies during multidisciplinary pain management 
interventions has been shown to be a significant predictor of pain outcomes. Despite 
these findings, the reasons patients adhere to self-management strategies is poorly 
understood. Therefore, it is difficult to know in what way to best improve adherence 
in order to maximise treatment-related gains. Readiness to adopt new pain behaviours 
has shown promise as a construct that can be used to predict adherence to prescribed 
pain behaviours.  
 
This research project comprised of an empirical study and a meta-analysis and 
systematic review. The meta-analysis and systematic review aimed to determine 
whether motivational interviewing approaches are effective in improving adherence, 
pain and physical function for patients with chronic pain. The results from seven 
studies indicate that MI leads to short-term increases in adherence to chronic pain 
treatments, although publication bias cannot be ruled out as an explanation for the 
findings. Further, it is as yet unclear whether these effects result in improvements in 
patient function.  
 
After establishing preliminary evidence that motivational interviewing approaches 
increase adherence to chronic pain treatment, an empirical study was established to 
explore the potential mechanisms associated with such increases. The study was 
primarily designed to determine whether readiness to adopt pain self-management 
strategies predicted these behaviours in a three-week multidisciplinary pain 
management program. The study also explored the relationship between individual’s 
beliefs about the perceived benefit in using self-management strategies and adherence 
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to these strategies. The treating clinical psychologist rated participants adherence to 
each self-management strategy taught in the pain management program at the end of 
each week using a scale of 0 to 2, where 0 = ’not using the strategy at all’, 1 = ’using 
it inconsistently’, and 2 = ’using it consistently’. 
 
One hundred and nineteen participants consented to participate in the study. The 
major finding of this study was that individual’s perceived benefit in adopting self-
management strategies early in treatment predicted small improvements in pain 
management coping behaviours in subsequent weeks of the program, particularly 
perceived benefit in the first week of the program. Interestingly, no strong bi-
directional relationships were observed. That is, adherence did not predict 
individual’s perceived benefit in using self-management strategies in subsequent 
weeks. Contrary to expectations, readiness to adopt pain management strategies at 
baseline was not associated with adherence to self-management strategies during any 
week of the three-week program. Furthermore, this study failed to replicate the robust 
findings of past research that showed adherence to be an independent predictor of 
pain outcomes.  
 
The findings of this research project raises questions about the theoretical and clinical 
application of the transtheroetical model and the motivational model of pain self-
management in chronic pain. Based on the findings, other health psychology models 
such as the health belief model may have more value for predicting adherence to 
chronic pain treatment. This research project also highlights the importance of 
individual’s expectancies and the process of change in chronic pain treatment. In 
particular, there is a need for more process-oriented research that assesses the 
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temporal aspects of change so that an understanding of the mechanisms of change can 
be identified. This would in turn inform how current approaches to chronic pain 
treatment can be improved. Finally, the findings of the empirical study stress the need 
for valid and reliable measures of adherence that not only gauge participant adherence 
but therapist fidelity to therapeutic processes.   
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CHAPTER 1 
Literature Review 
 
1.1 Prevalence and impact of chronic pain 
Chronic pain conditions affect a large proportion of the adult Australian population 
and are associated with significant burden on the individual and the Australian health 
and welfare sector. According to Australia’s largest prevalence study, approximately 
one in five Australian adults reported chronic pain (Blyth, March, Brnabic, Jorm, 
Williamson & Cousins, 2001). The authors found that over half of the individuals 
who reported chronic pain stated that their pain interfered with their daily activities. 
Furthermore, almost 7% of the Australian population have chronic pain that 
significantly impacts on their ability to work and carry out every day tasks. Compared 
with adults with no chronic pain, chronic pain is associated with twice the prevalence 
of hospitalisations and general practitioner (GP) visits in the last year and five times 
the prevalence of emergency department visits in the last year (Blyth et al., 2001).  
Moreover, experiencing chronic pain was significantly associated with receiving a 
disability or unemployment benefit, being unemployed for health reasons, having 
poor self-rated health and high levels of psychological distress.  
 
Demyttenaere et al., (2007) conducted a study of the prevalence of mental disorders 
according to the Composite International Diagnostic interview across 17 countries 
globally, including both developing and developed countries. The authors found that 
there was a higher prevalence of a range of anxiety (e.g. Generalised anxiety disorder 
and panic disorder) and mood disorders and alcohol misuse among those with chronic 
back and neck pain and this relationship was observed in both developing and 
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developed countries. These findings are consistent with the findings of a literature 
review on the relationship between depression and pain conducted by Bair and 
colleagues (2003). Their literature review revealed that individuals with depression 
had higher rates of pain than the general population and similarly individuals with 
pain had higher rates of depression that the general population. They also found that 
individuals experiencing pain were less likely to be identified as experiencing 
depression, which meant that the pain population were less likely to be treated for 
depression. Individuals with moderate to severe pain were more likely to have more 
depressive symptoms, lower reported quality of life, diminished work function and 
higher rates of health care utilisation than those with mild pain or no pain. 
Furthermore, the authors found that pain and depressive symptom were additive with 
regard to their financial impact on the health care system and incidence of medical 
visits. Similarly, Kroenke et al. (2013) examined the association between anxiety and 
health related quality of life and functional impairment and their findings suggest that 
pain populations have higher rates of anxiety disorders. Critically, pain populations 
with comorbid anxiety and pain were associated with significant functional 
impairment and reduced quality of life compared with either of these populations 
individually, even after controlling for depressive symptoms. 
 
According to the Medical Benefits Fund Incorporated (MBF) foundation the overall 
financial cost of chronic pain in Australia was estimated to be $34 billion in 2007. 
The MBF estimated that the largest cost was associated with lost productivity, 
reflecting the impact of chronic pain on work performance and employment 
outcomes. A further $7 billion was estimated to be the cost of direct health care (MBF 
Foundation, 2007). Prevalence studies in other western countries show comparable 
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rates of chronic pain and highlight the costs of chronic pain on the affected individual 
and the community (Breivik, Collett, Ventafridda, Cohen & Gallacher, 2006; Gureje, 
Von Korff, Simon & Gater, 1998). For example, Breivik et al. (2006) found that 61% 
of individuals with chronic pain were unable or less able to work outside of their 
home and that 60% of individuals with chronic pain had visited their treating doctor 
about their pain between 2-9 times in the past six months. Chronic pain has also been 
shown be a significant burden on individual’s quality of life due to higher rates of 
psychological co-morbidities. Given the significance of chronic pain, it is important to 
understand why some people following an injury recover but others don’t.  
 
1.2 Theories of chronic pain 
Traditional medical treatments, rooted in the biomedical model, are largely ineffective 
in reducing the myriad of lifestyle difficulties and disability associated with chronic 
pain conditions (Gatchel, Peng, Peters, Fuchs & Turk, 2007; Turk, 2005). According 
to the biomedical model, chronic pain stems from structural damage or physical 
abnormalities and therefore medical treatments focus on resolving physical causes of 
pain (Gatchel et al., 2007). These medical treatments fail to account for individual’s 
experience of pain where there is no identifiable injury, physical abnormality or 
following the full physical recovery of an acute injury (Gatchel et al., 2007). 
Traditional biomedical approaches are insufficient in understanding and managing 
chronic pain, as they do not account for fundamental psychological and social facets 
of these conditions.  
 
Contemporary theories of chronic pain propose that chronic pain is best understood as 
a complex interaction between biological changes, psychological processes and 
 18 
socioeconomic factors, as encapsulated in the biopsychosocial model of chronic pain. 
According to the biopsychosocial model, psychological variables (such as beliefs 
about pain, emotions and pain related behaviour) and social variables (such as social 
support networks, cultural values and socioeconomic standing) are important in 
understanding the aetiology, maintenance and treatment of chronic pain (Gatchel et 
al., 2007). Thus, the biopsychosocial model builds on the biomedical models view of 
chronic pain as a disease and acknowledges the importance of an individual’s 
subjective experience or perception of their pain (Gatchel et al., 2007). The fear-
avoidance model is one of the most commonly cited biopsychosocial models of 
chronic pain and provides a sound framework for understanding the development, 
maintenance and treatment of chronic pain conditions.  
 
The fear-avoidance model of chronic pain proposes that pain invokes a set of 
cognitive, emotional and behavioural responses that either lead to recovery or further 
pain and disability. According to this model that was initially proposed by Vlaeyen & 
Linton (2000), individuals who interpret their pain as non-threatening are likely to 
resume their physical and social activities, often after a short period of rest. This 
approach allows the individual to test their expectations about pain and to correct their 
future expectations based on their actual experience. This is thought to then promote 
recovery. On the other hand, individuals who misinterpret their pain as being 
catastrophic, such as due to a serious injury over which they have limited control, are 
likely to develop a fear of pain and re-injury. Consequently, these individuals are 
likely to display a range of safety seeking behaviours. For example, individuals will 
avoid physical movements that are thought to make their pain worse, which 
eventually leads to the avoidance of regular physical and social activities. Moreover, 
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individuals may develop attentional biases in the form of hypervigilance to pain 
signals or injury over time. This makes the individual more likely to interpret 
ambiguous information as pain related, and attentional resources are likely to be 
guided toward pain-related information at the expense of other pain-unrelated 
information. Functionally, avoidance and hypervigilance do not allow the individual 
to test their catastrophic interpretations with actual experience and as a result these 
individuals are likely to overestimate current pain intensity, future pain and the 
possible negative meaning of pain, leading to continued pain and further disability 
(Vlaeyen & Linton, 2000).  An increasing number of studies have attempted to 
validate parts of this model since its inception.  
 
The fear-avoidance model of chronic pain has received strong empirical support. 
Numerous cross sectional and prospective studies have focused on validating the 
interrelationships between the various components of the fear-avoidance model. For 
example, there appears to be a reliable association between pain catastrophising and 
disability (Peters, Vlaeyen & Weber, 2005; Sullivan, Lynch & Clark, 2005; Turner, 
Mancl & Aaron, 2004) and pain catastrophising and pain intensity (Buer,& Linton, 
2002; Severeijns, Vlaeyen, van den Hout & Weber, 2001; Turner, Jensen, Warms & 
Cardenas, 2002). Studies have shown that fear of pain and hypervigilance to pain are 
independent predictors of the experience of pain and pain intensity (Arntz & 
Claassens, 2004; Roelofs, Peters, Patijn, Schouten & Vlaeyen, 2004). Furthermore, 
Leeuw, Goossens, Linton, Crombez, Boersma & Vlaeyen (2007) presented an 
overview of the evidence supporting the association between safety behaviours (such 
as escape/avoidance behaviour and hypervigilance) and disability in chronic pain 
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conditions, as well as the relationships between pain related fear and the development 
and maintenance of chronic lower back pain.  
 
While the fear-avoidance model of chronic pain has received the most empirical 
citations recently, most other theories of chronic pain share numerous theoretical 
overlap (such as the cognitive model proposed by Turk, Meichenbaum & Genest, 
1983) and highlight the roles of psychological processes and their function in 
maintaining chronic pain. Until the 1960’s the medical model of chronic pain was 
universally accepted. The Gate Control Theory of Pain marked a significant 
theoretical shift toward current psychosocial treatments as it began to appreciate that 
the medical model did not account for chronic pain (Melzack & Wall, 1967). This 
eventually led to the adoption of current biopsychosocial models of chronic pain.  
Turk and Okifuki (2002) describe a biopsychosocial model of chronic pain that 
focuses on individuals pre-existing beliefs about the meaning of symptoms, 
individuals interpretation of the onset of pain, fear avoidance, self-efficacy and their 
readiness to change pain related behaviour. This model captures the key tenants of the 
fear avoidance model, though pays more attention to individuals beliefs about their 
ability to cope. For example, they propose that individuals who believe that they can 
meet their goals despite pain are more likely to cope than those individuals with weak 
self-efficacy beliefs. The authors also focus on the motivational context for pain 
related behaviours and the impact of these motivational factors on an individual’s 
recovery or path to disability. Similarly, Crombez, Eccleston, Van Damme, Vlaeyen 
& Karoly (2012) propose an updated fear avoidance model to account for individuals 
goals and motivational processes that were not accounted for by the original fear 
avoidance model. In short, this model expands on the original fear avoidance model 
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by encapsulating how individuals attempt to meet their valued goals or activities, 
particularly when multiple competing goals exist. They propose that these 
motivational processes impact on the individual’s behaviour and subsequently their 
eventual recovery or disability. In other words, recovery and disability are not simply 
a result of a fear of pain or re-injury. The original fear avoidance model (Vlaeyen and 
Linton, 2000), the biospychoscial model of chronic pain outlined by Turk and Okifuji 
(2002) and the most recent update of the fear avoidance model (Crombez et al., 2012) 
all attempt to provide a model of why individuals develop and maintain pain and 
disability and the factors associated with recovery. Since these models are all based 
on psychological processes that are clearly defined and are able to be tested, this has 
led to the development of efficacious psychological treatments.  
 
1.3 Psychological treatment of chronic pain 
Effective psychological treatments for chronic pain have been developed following 
the findings that psychological processes appear to play a central role in the 
development and maintenance of individuals experience of chronic pain. A recent 
review by Eccleston, Morley and Williams (2013) concluded that cognitive 
behavioural therapies (CBTs) were the most efficacious psychological interventions 
for chronic pain. This review highlights the strong evidence that CBT leads to 
improvements in pain intensity, levels of catastrophising, depressive symptoms and 
disability. However, although the abovementioned findings seem robust, systematic 
review and meta-analyses have demonstrated that effects sizes are only small and are 
clearly suboptimal (Eccleston, Williams & Morley, 2009; Williams, Eccleston & 
Morley, 2012).  Thus, while CBT appears to be a promising intervention for chronic 
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pain, understanding the mechanisms through which cognitive behaviour treatments 
effect change is necessary to improve the reported small effect sizes. 
 
The small and suboptimal effect sizes of CBT for chronic pain reported in recent 
systematic review and meta-analyses are likely due to a number of factors. First, there 
is clear heterogeneity in pain conditions and outcome variables assessed in these 
studies. Studies incorporated in these reviews attempt to draw conclusions about the 
efficacy of CBT for chronic pain by including together a range of chronic pain 
conditions, despite each condition inherently containing different primary outcome 
variables. For example, the primary outcome for individuals with chronic lower back 
pain is generally disability and not pain intensity (Guzmán, Esmail, Karjalainen, 
Malmivaara, Irvin & Bombardier, 2001). On the other hand, the primary outcome for 
individuals with rheumatoid arthritis is usually pain intensity and not disability 
(Richards, Whittle & Buchbinder, 2012). Due to the inherent heterogeneity among 
these parameters, which are then amalgamated for estimating treatment efficacy, the 
overall reported effect of CBT on chronic pain is likely to be somewhat diluted 
(Eccleston, Morley & Williams, 2013; Morley, 2011; Morley, Williams & Eccleston, 
2013). Second, more than 50% of the individuals included in these reviews do not 
score in the clinical range for depression and anxiety. As a result, there is little room 
for large improvements in depression and potentially other pain outcome measures. 
Finally, the quality of cognitive behavioural interventions included in these reviews is 
relatively poor. Williams, Eccleston and Morley (2012) noted that although there has 
been a significant improvement in the overall quality of studies assessing the effect of 
CBT on chronic pain over time, the overall quality of study treatments has not 
improved. There is currently only one RCT that uses the gold standard of in-patient 
 23 
intensive multidisciplinary treatment that is based on cognitive behavioural self-
management strategies. This is likely to result in the underreporting of treatment 
effectiveness.  
 
Multidisciplinary pain management programs that incorporate cognitive behavioural 
self-management strategies are effective in improving pain outcomes, consistently 
demonstrating much larger effect sizes than those reported in recent systematic review 
and meta-analyses. For example, Nicholas and colleagues (2012; 2014) have 
demonstrated that a three-week cognitive behavioural pain management intervention 
that promotes self-management strategies results in significant reductions in pain 
severity, depression and disability, with small to medium to large effect sizes. These 
studies reported that the average effect size across all outcome variables was 0.69, 
ranging from 0.42 to 1.01 (Nicholas et al., 2012) and 0.64, ranging from 0.61 to 1.45 
(Nicholas et al., 2014). These findings are comparable to other multidisciplinary pain 
management programs that are based on cognitive behavioural principles and promote 
self-management strategies (Morley, Williams & Hussain, 2008). Although 
multidisciplinary pain management treatments based on CBT have consistently been 
shown to improve pain outcomes with small to medium to large effect sizes, 50% of 
patients fail to make clinically significant improvements and some of those who do 
improve relapse (Morley, Williams & Hussain, 2008; Nicholas et al., 2012; 2014). 
Therefore, it is clear that there is considerable scope to improve outcomes from these 
programs. One way to do so is to try and understand what factors predict the 
outcomes from these programs and then attempt to develop strategies that specifically 
target these issues (Williams, Eccleston & Morley, 2012).   
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1.4 Predictors of cognitive-behavioural treatment outcomes in chronic pain 
Despite the strong empirical support of CBT for chronic pain, little is known 
regarding the unique processes or treatment variables that contribute to treatment 
outcomes. To date, only a handful of studies assess the processes of change in CBT 
based interventions for chronic pain (Morley, Williams & Eccleston, 2013). 
Typically, these studies assess a few potential mediators or moderators of change, 
such as self-efficacy or catastrophising and find that the factor in question is 
significantly associated with treatment outcomes. For example, two studies assessing 
the role of self-efficacy on treatment outcomes found that self-efficacy appears to be a 
significant predictor of individuals change in disability, depressive symptoms and use 
of pain coping strategies (Turner, Ersek & Kemp, 2005), although it does not 
eliminate the contributing role of pain intensity on all these outcomes (Arnstein, 
Caudill, Mandle, Norris & Beasley, 1999). Furthermore, one study demonstrated that 
self-efficacy was a better predictor of treatment outcome than individuals reported 
readiness to adopt pain self-management strategies (Strong, Westbury, Smith, 
McKenzie & Ryan, 2002). These studies that only assess one or two predictors of 
treatment outcomes do not account for the complex interrelationship among other 
potential factors that contribute to change, thus providing an incomplete or inaccurate 
representation of their roles or predictive ability. This is particularly problematic 
when there are strong inter relationships between different predictors. 
 
Studies that have looked at multiple predictors of treatment outcomes among 
individuals with chronic pain have reported mixed findings, making it hard to draw 
any firm conclusions on the key processes of change. Turner, Jensen and Romano 
(2000) found that pain-related beliefs, the use of coping strategies and levels of 
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catastrophising significantly predicted disability and depressive symptoms following 
treatment. However, pain-related beliefs were only associated with disability and 
depressive symptoms, the use of coping strategies was only associated with disability, 
while levels of catastrophising was only associated with depressive symptoms. 
Turner, Holtzman and Mancl (2007) conducted one of the most methodologically 
sound studies that aimed to determine the mediators and moderators of treatment 
outcomes in CBT for chronic pain. As potential factors that contributed to treatment 
outcomes, they assessed individual’s beliefs about their perceived control over pain, 
perceived level of disability, extent to which they believed that pain signals harm, 
catastrophising and self-efficacy. They found that changes in individual’s perceived 
control over pain during the CBT program accounted for most of the treatment effect 
of CBT on pain outcomes. However, across groups, self-efficacy was a unique 
mediator of CBT on pain outcome, over and above changes in perceived control over 
pain. Finally, Vowles, McCracken and Eccleston (2007) found that changes in 
acceptance beliefs and catastrophising, but not pain intensity accounted for changes in 
treatment outcomes during a cognitive behavioural pain management program.  Thus, 
it appears that predicting pain outcomes are dependent on which predictors are 
examined and the relationship between them.  When predictive factors are assessed in 
isolation then they appear to highlight mechanisms of change in treatment outcomes. 
However, when numerous factors are assessed together so that the unique variability 
of each predictor can be determined, this process of change is less clear, likely due to 
the high inter-correlations between the different measures.  
 
It has recently been proposed that adherence is an important predictor of treatment 
outcomes of CBT for chronic pain. Nicholas and colleagues (2012) sought to 
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determine whether adherence to pain self-management strategies during a three-week 
outpatient CBT pain management program had an effect on pain related disability, 
pain intensity and depression severity in a sample of 567 consecutive patients with 
chronic pain. Importantly, the authors controlled for participant’s self-efficacy, 
catastrophising and fear-avoidance beliefs so that the unique role of adherence could 
be determined while accounting for these key cognitive process measures known to 
moderate treatment outcomes. So that adherence ratings best reflected the 
participant’s adherence to the five self-management strategies assessed throughout the 
program (i.e. activity pacing, goal setting, desensitisation or interoceptive exposure, 
thought challenging and stretch exercises), an adherence rating system was developed 
whereby participants adherence was rated as either: ‘not using the strategy’, ‘using it 
inconsistently’ or ‘using it consistently’. The authors found that adherence to self-
management strategies during the three-week multidisciplinary pain management 
program were a significant predictor of improved pain outcomes post treatment, 
including pain severity, disability and depression. The authors also found a strong 
relationship between participant’s level of adherence and outcomes, whereby patients 
achieved better outcomes the more consistently they adhered to the self-management 
strategies. Notably, this relationship remained even after controlling for baseline 
factors, such as pain self-efficacy, catastrophising and fear-avoidance beliefs that are 
known to moderate pain outcomes. 
 
Adherence also appears to be a key predictor of long-term pain outcomes. Nicholas et 
al. (2014) replicated the findings of their prior study in a sample of 140 participants, 
showing that adherence during the pain management program was the single best 
predictor of pain outcomes post treatment. However, the most recent study also 
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assessed pain outcomes at one, six and twelve months post treatment. Follow up of 
these participants demonstrated that individual’s level of adherence during the three-
week program was associated with treatment outcomes up to a year post treatment. 
Those who adhered consistently throughout the program made greater improvements 
in pain outcomes post treatment than those who did not adhere consistently. More 
notably, the high adherence group almost doubled the effect size (d =1.1) over the 
following year, whereas the low adherence group maintained their gains but failed to 
make further gains (d = 0.65). This suggests that not only do highly adherent patients 
do better during the program, but crucially in the longer term too. While adherence 
seems to be a strong predictor of treatment outcomes of CBT for chronic pain, over 
and above other relevant variables, the reasons patients adhere to self-management 
strategies is poorly understood. It is therefore difficult to know in what way to best 
improve adherence in order to maximize treatment related gains.  
 
1.5 Overview of motivational model of pain self-management  
The motivational model of pain self-management proposed by Jensen, Nielson and 
Kerns (2003) provides a theoretical framework for understanding adherence to pain 
self-management strategies. The authors critically reviewed key theories on the 
motivational issues surrounding coping and the self-management of pain before 
attempting to tie these vastly overlapping concepts into a coherent, dynamic model of 
motivation for pain self-management. This model, as presented in their review, is 
replicated in Figure 1. Within this model, the primary outcome is adherence to self-
management behaviours, also described as coping behaviours. These behaviours 
consist of those self-management behaviours and cognitions that are considered 
adaptive or conversely the avoidance of maladaptive behaviours. These are also the 
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behaviours that are frequently promoted in multidisciplinary pain management 
programs, such as exercise, pacing, task persistence, and the avoidance of 
catastrophising and pain medication.  
 
At the core of this model is readiness to change self-management strategies, which 
represents the authors’ definition of motivation. The authors postulate that 
individual’s will adhere to specific pain self-management strategies as a function of 
their readiness to use these strategies. Thus, they argue that individual’s readiness to 
change should be a focus of pain management programs as it is a tangible construct 
that can be modified by clinicians and is believed to facilitate adoption of the adaptive 
self-management behaviours they strive to promote. For example, prior to entry into 
pain management programs, clinicians could assess individual’s readiness to adopt 
various pain self-management strategies and apply targeted interventions that aim to 
increase motivation among individuals deemed precontemplative or contemplative in 
their readiness to use these behaviours. Readiness to change and the application of 
this construct to chronic pain is discussed in more detail below.  
 
The authors propose that readiness to adopt self-management strategies is influenced 
by two independent factors: perceived importance of engaging in pain self-
management behaviours (referred to below simply as ‘perceived importance’) and 
self-efficacy. Perceived importance is defined as beliefs about the importance of 
engaging versus not engaging in self-management strategies. While not intended to be 
exhaustive, the key beliefs underlying perceived importance concern weighing up the 
expected advantages and disadvantages of adopting pain self-management strategies 
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on valued outcomes (for example, pain intensity and levels of disability) and prior 
learning experiences. On the other hand, the authors propose that self-efficacy is 
formed through an individual’s personal experience, modeled behaviours from others, 
verbal persuasion and perceived barriers.  
 
 
Fig 1. Proposed motivational model of pain self-management as presented in Jensen, 
Nielson & Kerns (2003).  
 
Finally, the authors emphasise that this is a dynamic model of individual’s motivation 
to adopt pain self-management strategies. As such, it is believed that there are a 
number of factors that can impact on an individual’s readiness to adopt these 
behaviours. For example, it is believed that new experiences of using self-
management strategies, modeled behaviours of others (particularly relevant for group 
programs) and clinician behaviour influence an individual’s perceived importance and 
self-efficacy in using self-management strategies. This in turn is thought to influence 
an individual’s readiness to adopt and adhere to these behaviours.   
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1.6. Perceived benefit in using self-management strategies 
The idea that an individual will engage in a specific behaviour (such as a pain self-
management strategy) because they perceive a benefit in doing so is not unique to the 
motivational model of pain self-management and has roots in social learning theory 
(Bandura, 1977), social cognitive theory (Bandura, 1986) and is a core component of 
the health belief model (Rosenstock, 2000). These theories share a similarity in that 
they propose that the likelihood that an individual engages in a certain behaviour 
occurs as a function of the individual’s beliefs about the outcome of that behavour 
(i.e. their expectations) and their beliefs about their ability to perform the behavoiur 
(i.e. their self-efficacy). Accordingly, these theories would propose that an individual 
would adhere to a pain self-management strategy when they perceive a benefit and 
believe that they are capable of performing this behaviour. There is strong evidence 
that self-efficacy is a key moderator of health related behaviours in chronic pain. For 
example, self-efficacy has been shown to be associated with adaptive coping 
behaviours (Jensen, Turner & Romano, 1991; Schiaffino, Revenson & Gibofsky, 
1991), it predicts return to the workforce following pain treatment (Robbins, Moody, 
Hahn & Weaver, 1996) and has been shown to predict exercise among individuals 
with knee osteoarthritis (Rejeski, Martin, Ettinger & Morgan, 1998). In contrast, no 
studies to date have assessed the specific relationship between individuals perceived 
benefit of performing self-management strategies and adherence to these strategies or 
pain outcomes in chronic pain. Given the strong theoretical support for this concept 
and the fact that it is a key tenant of the motivational model of pain self-management, 
exploring the importance of perceived benefit and adherence to pain self-management 
strategies would enhance our understanding of current health psychology models and 
would have implications for clinical practice. For example, if the proposed 
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relationship in the motivational model were validated and individuals perceived 
benefit was a unique predictor of adherence to pain self-management strategies, 
enhancing individuals perceived benefits of adopting these strategies during treatment 
might improve current treatment adherence and subsequent outcomes.  
 
1.7 The transtheoretical model and adherence in chronic pain 
According to Jensen, Neilson and Kerns’ (2003) motivational model of pain self-
management, the most significant predictor of adherence to pain self-management 
strategies is the degree to which participants are ready to adopt these prescribed 
behaviours. The construct of readiness to change derives from Prochaska and 
DiClemente’s (1984) Transtheoretical Model of Behaviour Change (TTM). This 
model arose following a comparative analysis that aimed to identify the various 
processes and principles of behavoiur change by incorporating a range of major 
behaviour change theories and interventions, hence the term ‘transtheroetical’ 
(Prochaska, 2013). The comparative analysis focused on the differences between 
individuals who stopped smoking on their own with smokers receiving professional 
treatment (Di Clemente and Prochaska, 1982). The analysis identified ten processes 
from a range of psychological traditions that were predictive of successful behaviour 
change, such as consciousness raising, contingency management and helping 
relationships. They found that participants relied on different processes at different 
times throughout their attempt to stop smoking, highlighting the concept that 
behaviour change does not simply occur as a single event but rather over time through 
a series of stages (Prochaska & DiClemente, 1983; Prochaska & Velicer, 1997).  
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The TTM considers the temporal aspect of behaviour change as a core construct, 
defined as ‘stages of change’. The stage of change construct speculates that 
individuals go through six distinct stages before adopting and maintaining new 
behaviours: precontemplation, contemplation, preparation, action, maintenance and 
termination (Prochaska & Velicer, 1997). Each stage categorises the individuals 
intention to change their behaviour, the level of insight they have regarding the 
consequences of their behaviour and their willingness to appraise their behaviour. The 
characteristics of each stage, as outlined by Prochaska and Velicer (1997), are 
described in turn. In the precontemplation stage, individuals are not considering 
behaviour change in the near future and they lack an awareness of the consequences 
of their behaviour. Individuals in this stage typically avoid reading, discussing or 
thinking about the problematic behaviour. In the contemplation stage, individuals 
have an intention to change their behaviour but not imminently and they are largely 
ambivalent about behaviour change. They are aware of the negative consequences of 
their behaviour but are still attached to the benefits. Individuals in this stage are 
willing to discuss the consequences of their behaviour though put off actual 
behavioural modification. In the preparation stage, individuals have an intention to 
change in the immediate future and they often make minor behavioural modifications, 
though not big enough behavioural changes to significantly reduce the negative 
consequences of their behaviour. They are aware that the negative aspects of their 
behaviour outweigh the positives. Individuals in this stage have often developed a 
plan to change their behaviour but are not ready to fully implement it. In the action 
stage, individuals are making significant attempts to change their behaviour. They are 
aware of the action required to significantly reduce the negative consequences of their 
problematic behaviour and are actively monitoring the outcomes associated with their 
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behaviour modification. Individuals in this stage are often still building their self-
efficacy in applying a new behaviour. In the maintenance stage, individuals intend on 
preventing a return to their problematic behaviour. They are less tempted to engage in 
the maladaptive behaviour and have increased self-efficacy in applying the adaptive 
behavour. Finally, in the termination stage, individuals have no drive to re-engage in 
their maladaptive behaviour and have strong self-efficacy with regard to maintaining 
their adaptive behaviour. This stage is not always reached by many individuals and 
can be considered a ‘cure’ from the initial problematic behaviour.    
 
Readiness to change has been shown to be a good predictor of treatment outcomes in 
the drug and alcohol field. For example, Zhang, Harmon, Werkner and McCormick 
(2004) assessed readiness to change and alcohol use severity among 390 participants 
with a dual diagnosis of problematic alcohol use and persistent and severe mental 
health conditions (such as schizophrenia) who were receiving treatment as usual. 
They reported that readiness scores at baseline predicted alcohol consumption nine 
months following assessment whereby individuals who were highly ambivalent about 
their alcohol consumption consumed significantly more alcohol at nine month follow 
up than individuals with lower ambivalence about their alcohol consumption.  
 
Readiness to change has also been demonstrated to predict adherence to treatment in 
the drug and alcohol field, where these concepts originated. Joe, Simpson and Broome 
(1998) demonstrated the predictive validity of the stages of change construct and 
adherence to drug treatment. They examined the relationship between self-reported 
motivation to reduce drug use and subsequent therapeutic engagement and treatment 
retention in a sample of 2265 participants from various drug treatments settings.  The 
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authors found that individuals who reported higher levels of readiness to reduce their 
drug use at the start of treatment were more likely to stay in treatment for at least 90 
days in long-term residential settings and at least 360 days in outpatient methadone 
treatment settings. In addition, higher readiness scores were associated with greater 
therapeutic engagement, such as actively doing things to achieve treatment goals and 
making attempts to change. These findings suggest that readiness not only predicted 
retention in treatment but adherence to the active component of treatment that one 
would consider necessary to achieve optimal treatment goals.  
 
Due to the growing support for the TTM and the concept of stages of change in the 
drug and alcohol field, drug and alcohol treatment now incorporates individual’s 
readiness to change in best practice guidelines (Copeland, Frewen & Elkins, 2009; 
Marsh, Dale & Willis, 2007). In particular, the drug and alcohol field have adopted 
the central notion of the TTM that treatment is most effective when it is tailored to the 
individual’s stage of change. For example, it is considered best practice to use insight-
based motivational approaches, such as motivational interviewing, for those 
individuals who have not considered (precontemplation) change or for those 
considering (contemplation) change. In contrast, active skills based treatments, such 
as CBT are indicated for individuals who are planning to change their drug and 
alcohol use (preparation), those in the process of changing their behaviour (action) or 
those who are trying to maintain their reduction or abstinence from drug and alcohol 
(Connors, DiClemente, Velasquez & Donovan, 2012). Thus, in the field of addiction, 
the TTM and stage of change construct has been shown to predict treatment 
adherence and outcomes, which has in turn influenced clinical practice. In contrast, 
research in the field of chronic pain has largely been based on health psychology 
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models, which have not been as successful in predicting behaviours in response to 
chronic health conditions.  
 
 The major health psychology models that focus on constructs such as beliefs about 
the seriousness of an individual’s health condition (e.g. fear of re-injury) and coping 
strategies (e.g. catastrophising) have not been as successful as the TTM in predicting 
health behaviours and subsequent outcomes. For example, the Health Belief Model 
(Rosenstock, 2000) proposes that an individual’s likelihood of adopting adaptive 
health behaviours are influenced by five core elements: 1) perceived severity of the 
health condition and the perceived impact of the condition for the individual; 2) 
perceived likelihood that the individual will suffer from the condition; 3) the reminder 
of either internal or external cues to perform the behaviour, such as experiencing 
acute symptom of the condition or explicit communication from a health care 
provider; 4) perceived advantage of performing a specific behaviour; 5) perceived 
difficulties in performing a specific behaviour. The health belief model has been 
shown to be good at predicting simple behaviours where the outcome of a behaviours 
is directly associated with positive outcomes, such as taking anti-epileptic medication 
to manage epilepsy. However, this model is less successful at predicting more 
complex behaviours, where the behaviour is not directly related to the outcome of the 
behaviour, such as exercise for individuals with rheumatoid arthritis (Sharpe & 
Curran, 2006). Furthermore, the Theory of Planned Behaviour (Ajzen, 1991) has been 
shown to be a good predictor of the intention to perform a behaviour, but not the 
actual behaviour, nor the outcome associated with the behavoiur (Sharpe & Curran, 
2006). As a result, it is plausible that the TTM may be more successful at predicting 
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adherence to chronic pain treatment and subsequent outcomes than health psychology 
models and is therefore a worthy area for further investigation.   
 
The large majority of studies assessing individual’s readiness to adopt pain self-
management strategies utilise the Pain Stages of Change Questionnaire (PSOCQ). 
This measure was developed by Kerns, Rosenberg, Jamison, Caudill and 
Haythornwaite (1997) and is designed to assess four distinct stages of an individual’s 
overall willingness to adopt pain self-management strategies: Precontemplation, 
contemplation, action and maintenance. According to the authors, those in 
‘precontemplation’ are thought to be unwilling or not considering adopting self-
management strategies. Those in ‘contemplation’ are thought to be considering the 
use of self-management strategies but are undecided and are still to an extent seeking 
a medical cure. Those in ‘action’ are thought to be motivated to adopt prescribed self-
management strategies and are in the process of developing related skills. Finally, 
those in ‘maintenance’ are thought to be using but still consolidating and refining 
already learnt pain self-management strategies.  
 
A number of studies have shown that patient’s readiness to change, as measured by 
the PSOCQ, reliably predict completion of pain management programs. In an attempt 
to predict the completion of a ten-session cognitive-behavioural pain management 
program, Biller, Arnstein, Caudill, Federman and Guberman (2000) conducted a 
prospective cohort study and assessed individuals overall readiness to adopt pain self-
management strategies by administering the PSOCQ prior to treatment. They found 
that initial PSOCQ scores predicted completion of this program. Low 
precontemplation scores were the best predictor of dropout, correctly predicting 61% 
 37 
of individuals who completed the program and 65% of those who did not. A recent 
study supported these findings, showing that individuals who score higher on 
precontemplation and lower on other subscales at pretreatment are less likely to 
complete treatment in a multidicisplinary pain management centre (Gersh, Arnold & 
Gibson, 2011). Similar results were demonstrated in another study assessing the 
completion of a different cognitive behavioural pain management program (Kerns & 
Rosenberg, 2000). Although it is reasonable to assume that patients need to complete 
a pain management program to benefit, recent studies have demonstrated that patients 
not only have to complete the program but they need to actually practice the skills to 
get optimal benefits (Nicholas et al., 2012; 2014). That is, completion of pain 
management programs may be necessary for patients to gain benefits but not 
sufficient for them to benefit optimally. The TTM may have potential in identifying 
those at risk of completing pain management programs, but their potential for 
identifying adherence to pain self-management strategies is unknown.  
 
Evidence that the stage of change construct is predictive of pain treatment outcomes, 
however, is less clear. In the study carried out by Kerns and Rosenberg (2000), 
individuals completed the PSOCQ and measures of pain treatment outcomes, such as 
depressive symptoms, pain severity and disability prior to and immediately after an 8-
12 session cognitive behavioural pain management program. They found that 
compared with individual’s with profiles consistent with the action subscales (low 
scores on the precontemplation subscale and high scores on the action subscale), those 
with profiles consistent with the precontemplative subscale (high scores on the 
precontemplation subscale and low scores on the action subscale) at baseline were 
just as likely to make improvements in depressive symptoms and disability, as long 
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they completed the pain management program. That is, even though the baseline 
PSOCQ scores predicted who would complete the program, they were not associated 
with pain treatment outcomes among those who remained in treatment. These 
findings indicate that the stage of change construct predicts completion of pain 
management programs, but not pain outcomes. Interestingly, improved treatment 
outcomes were associated with progression in PSOCQ scores from pre to post pain 
management program. The authors propose that the program itself may facilitate 
readiness to change, which is consistent with the evidence that these scores do 
improve over treatment. The authors also speculate that it may be this shift in beliefs 
about the relevance of self-management strategies that leads to greater adherence to 
pain self-management strategies. Alternatively, they may also reflect an increase in 
perceptions of self-control and self-efficacy. Both these interpretations are consistent 
with the motivational model of pain self-management and more research is needed to 
validate these mechanisms leading to treatment adherence. However, these findings 
are consistent with the notion that readiness to adopt self-management strategies and 
improved pain outcomes are mediated by adherence to these strategies.  
 
Subsequent studies assessing PSOCQ scores throughout multidisciplinary pain self-
management programs seem to support the idea that progression through the stages of 
change toward action and maintenance predict outcomes, though the robustness of 
this relationship is largely still unclear. Glenn and Burns (2003) assessed individuals 
PSOCQ scores prior to, at the mid-way point and following a four-week 
multidisciplinary pain self-management intervention in an attempt to determine 
whether scores affected improvements in pain outcomes. They also aimed to 
determine whether any changes in PSOCQ were associated with any therapeutic 
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gains. They found that individuals with a high precontemplation profile at 
pretreatment predicted significantly worse pain severity, pain interference and 
depression post treatment, compared with those with a high contemplation or action 
profile at pretreatment. Most notably, they found that progression across the stages of 
change toward action and maintenance throughout the intervention predicted 
improvements in pain severity, pain interference, depressive symptoms and general 
activity. Furthermore, individuals who progressed through the stages of change, such 
as from predominantly precontemplation to contemplation or contemplation to action 
profiles, only did so in the first two weeks of treatment. In contrast, pain outcome 
measures changed in the expected direction steadily throughout the four weeks, and at 
a greater rate in the final two weeks. Interestingly, Burns et al. (2005) found that the 
association between movement across the stages of change construct in the first two 
weeks and improvements in pain outcomes was dependent on readiness scores pre 
treatment. Specifically, improved outcomes associated with progression in the stages 
of change construct in the first two weeks were evident among those with 
contemplation, action or maintenance profiles but not precontemplation profiles at 
baseline. Moreover, after assessing the cross lagged relationships, Burns and 
colleagues reported that pre to mid-treatment changes in precontemplation and 
contemplation scores significantly predicted mid to post treatment changes in pain 
severity and disability, whereas the reverse was not true. That is, mid to post 
treatment changes in precontemplation and contemplation scores did not predict post 
treatment changes in pain severity and disability. These findings indicate a potential 
causal mechanism, whereby improved readiness scores and pain outcomes are 
mediated by a key process, such as adherence. 
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The abovementioned results support the idea that individual’s stage of change is 
dynamic and increases in readiness to adopt pain self-management strategies leads to 
improved pain outcomes. Presumably, individual’s increased readiness to adopt pain-
self management strategies and pain outcomes are mediated through adherence to 
these particular strategies. The findings reported by Burns and colleagues are in direct 
contrast to the findings reported by Kerns and Rosenberg (2000), who found that pre-
treatment PSOCQ scores did not predict treatment outcomes. However, they do 
support Kerns and Rosenberg’s (2000) conclusions that progression through the 
stages of change predicts outcomes. Furthermore, findings are consistent with the idea 
that adherence or beliefs about the benefit of engaging in pain self-management 
strategies may facilitate outcomes through a stage of change-specific therapeutic 
process, though it appears this may only be the case for individuals who are at least 
contemplating the use of self-management strategies prior to pain management 
interventions.  
 
An additional two studies assessing the relationship between readiness for change and 
clinical outcomes in multidisciplinary pain self-management programs provide further 
insight on the impact of progression through the change stages. Gersh, Arnold and 
Gibson (2011) found that pre treatment PSOCQ scores did not predict pain outcomes. 
Rather, progression through the stages in the expected direction (e.g. 
precontemplation to contemplation or contemplation to action) as opposed to those 
who stayed the same or regresses, predicted significantly more improvements in 
depressive symptoms, and disability but not pain intensity. This finding was 
supported even when controlling for pretreatment PSOCQ scores. That is, the authors 
found that individual’s with pretreatment precontemplation profiles who progressed 
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across the stages during treatment received significantly greater improvement in 
depressive symptoms and disability than individuals with pretreatment action profiles 
who did not progress across stages.  
 
The other study conducted by Jensen, Nielson, Turner, Romano and Hill (2003) found 
that readiness to self-manage pain, as measured by the PSOCQ, increased from pre to 
post treatment and follow up of a multidisciplinary pain management program. They 
also reported that changes in readiness to manage pain throughout treatment (pre to 
post treatment and post treatment to follow up) were associated with increased 
reporting of coping strategies. Since pain management programs teach coping 
strategies and the PSOCQ predicts changes in coping, adherence to these strategies 
could be the mechanisms through which PSOCQ predicts pain outcomes, though this 
has not been tested. To a large extent, these results replicate the findings of Kerns and 
Rosenberg (2000) but not Burns and colleagues (2003; 2005), as pretreatment 
PSOCQ scores did not predict outcomes. The findings from these two studies also 
strengthen the view that changes across the stages throughout treatment predict pain 
outcomes. Taken together, the stage of change model appears to be a useful 
framework in predicting completion of pain management programs. There appears to 
be a relationship between progression through the stages of change during treatment 
that facilitates treatment outcomes, though the nature of this facilitation and the 
impact of demographic profiles (such as the importance of pretreatment readiness to 
adopt pain self-management strategies) are still unclear. However, while the stage of 
change construct has the potential to predict treatment outcomes, its association with 
other known predictors of pain outcomes, such as self-efficacy, catastrophising and 
fear of re-injury, is unknown. As such, the clinical utility of the stages of change 
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construct when taking into account these already well established predictors of pain 
outcomes is uncertain.  
 
While readiness to adopt pain self-management strategies predicts completion of 
chronic pain treatment (Biller et al., 2000; Gersh, Arnold & Gibson, 2011; Kerns & 
Rosenberg, 2000), which seems necessary but not sufficient for optimal treatment 
outcomes, it is not yet evident whether readiness to adopt pain self-management 
strategies predicts treatment outcomes over and above other variables that are known 
to predict treatment outcomes. Only two studies to date have assessed individual’s 
readiness to adopt pain self-management strategies together with other known 
predictors of treatment outcomes. In an attempt to examine the utility of the PSOCQ 
to predict treatment outcomes, Strong et al. (2002) examined the predictive validity of 
stages of change and self-efficacy constructs among 107 participants with chronic 
pain attending a multidisciplinary pain management program. The authors found that 
self-efficacy was a better predictor of pain outcomes at discharge compared with 
readiness. Specifically, self-efficacy predicted significant improvements in disability, 
pain severity and general activity. On the other hand, individual’s stage of change 
only significantly predicted improvement in general activity and accounted for less 
variance in general activity than the self-efficacy construct. Interestingly, Strong and 
colleagues also found that individuals progressed along the stages of change 
continuum throughout treatment, suggesting that readiness may be used as process 
measure. In contrast, Hadjistavropoulos and Shymkiw (2007) found that readiness 
was a better predictor of treatment outcomes than self-efficacy. They assessed the 
predictive validity of the precontemplative and action subscales of the PSOCQ with 
self-efficacy and a range of other relevant variables such as pain locus of control 
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beliefs, pain-related anxiety and the patient-physician relationship on treatment 
outcomes across four multidisciplinary pain self-management programs. They 
discovered that the pretreatment PSOCQ scores predicted pain severity, disability, 
depression, pain-related anxiety and locus of control for managing pain post 
treatment. Importantly, when all variables were assessed together, precontemplative 
scores accounted for 49% of the treatment outcome variance. There is a clear need to 
assess and compare the clinical utility of the stages of change construct with other 
known constructs that are known to predict pain treatment outcomes.  
 
Critically, there has been no research to date assessing whether readiness predicts 
adherence to chronic pain treatment. Since adherence to pain management 
interventions has been shown to be an independent predictor of treatment outcomes, 
over and above other known predictors (Nicholas et al., 2012; 2014), it may be that 
adherence mediates the relationship between readiness and treatment outcomes. This 
assumption is consistent with the motivational model of pain self-management 
(Jensen et al., 2003) and the reported findings that completion of pain management 
programs does not predict pain outcomes but rather progression across the stages 
(presumably through adherence) predicts outcomes. This is evidently an important 
area for future research. 
 
1.8 Limitations in the measurement of readiness to change pain related 
behaviour in chronic pain 
The current evidence base in the stage of change literature for chronic pain is almost 
entirely based on research that has assessed readiness using the Pain Stages of Change 
Questionnaire (PSOCQ), which has a number of limitations. Although Kerns and 
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colleagues (1997) found good psychometric properties that supported a four factor 
structure, subsequent studies have not (Carr, Moffett, Sharp & Haines, 2006; Dysvik, 
Kvaløy, Stokkeland & Natvig, 2010; Jensen, Nielson, Romano, Hill & Turner, 2000; 
Jensen, Nielson, Turner, Romano & Hill, 2003; Røe, Damsgård, Fors & Anke, 2014; 
Strong, Westbury, Smith, McKenzie & Ryan, 2002). In addition to concerns about the 
validity of the PSOCQ subscales, this measure has been most heavily criticised for its 
lack of sensitivity in predicting individual’s readiness to adopt a range of different 
pain self-management behaviours (Glenn & Burns, 2003; Jensen et al., 2000; Kerns & 
Habib, 2004; Kerns & Rosenberg, 2000). Pain self-management programs require 
individuals to adhere to a variety of pain self-management behaviours, yet the 
PSOCQ only measures individuals overall readiness to adopt these behaviours, rather 
than inquiring about specific skills. It is likely that patients would be more ready to 
adopt some behaviours over others, and therefore the PSOCQ lacks sensitivity to 
predict outcomes. For example, it is not uncommon that an individual is largely 
precontemplative in their willingness to complete pain exposure or desensitization 
tasks. At the same time, this individual may be considered to be in the action stage 
with regard to their willingness to challenge catastrophic thoughts. This individual’s 
PSOCQ score would likely fall somewhere between these two stages (such as 
contemplative), effectively diluting their score and losing specificity. Since pain self-
management programs promote the adoption of a range of self-management 
strategies, a clinically useful measure would assess an individual’s stage of change 
across a range of specific behaviours.  
 
To address this concern, Nielson, Jensen, Ehde, Kerns and Molton (2008) developed 
the Multidimensional Pain Readiness to Change Questionnaire - second version 
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(MPRCQ2). The MPRCQ2 has been shown to be a valid and reliable measure of 
readiness to change a variety of pain self-management strategies among patients 
suffering chronic pain (Nielson et al., 2008). The MPRCQ2 shows promise as a 
clinical tool that can be used to target individuals who are less likely to adhere to 
certain pain self-management behaviours. However, there has not been any attempt to 
determine whether the MPRCQ2 predicts adherence to different self-management 
strategies and treatment outcomes compared with other patient-based characteristics, 
known to be associated with the outcome of pain management programs, such as self-
efficacy or catastrophising (Kratz, Molton, Jensen, Ehde & Neilson, 2011). 
 
 
1.9 Discussion and recommendations for future research 
The stage of change model has shown promise as a framework for predicting 
outcomes to chronic pain self-management programs. It has been established that 
readiness predicts completion of pain management programs but this is not sufficient 
for improvements in outcomes. Rather, improvements in pain outcomes are 
demonstrated in studies where participants are shown to progress across the stages of 
change (Burns et al., 2005; Gersh, Arnold & Gibson, 2011; Glenn & Burns, 2003; 
Kerns & Rosenberg, 2000). While it may be assumed that adherence is the 
mechanism of change through which readiness predicts pain outcomes, this has not 
been investigated. This empirical area of investigation is significant in the context of 
prior research that has indicated that the effect sizes of current cognitive-behavioural 
pain management programs are larger in those who are most adherent (Nicholas et al., 
2012; 2014). For example, it may be possible that incorporating interventions that aim 
at increasing individual’s readiness to engage in pain self-management strategies prior 
to or during the course of treatment may increase the effectiveness of current 
 46 
programs. Investigations into clinical interventions that aim to increase adherence to 
pain programs is an important direction for future research. This work will form the 
second chapter of this thesis by providing a meta-analysis and systematic review of 
motivational interviewing approaches in adults with chronic pain.   
 
In order to further understand the role of adherence in chronic pain treatment, 
particularly with respect to readiness and treatment outcomes, a number of 
investigations are necessary. First, investigations need to determine whether readiness 
predicts adherence. That is, are individuals that report high levels of readiness more 
likely to adhere to chronic pain treatment than those who report low levels of 
readiness? More specifically, there is a need to determine whether stages of change 
constructs predict the extent to which individuals who complete pain management 
programs adhere to specific pain self-management strategies and the consistency in 
which they do so.  As indicated in this review, there is growing evidence that the 
stage of change construct predicts completion of pain management programs. 
Completion of pain management programs can certainly be viewed a form of 
adherence, however it is not synonymous to adherence to the active components of 
treatment, such as self-management strategies. This area of research has implications 
for clinical settings. If a greater proportion of people who attend pain management 
programs not only complete the programs but also adhere to the self-management 
strategies, treatment efficacy should improve.   
 
Second, research needs to determine whether adherence mediates the relationship 
between readiness and treatment outcomes. In other words, do individuals who report 
higher readiness scores benefit from treatment because they are more likely to adhere 
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to the self-management strategies? In order to do so, research into stage of change 
constructs should assess individual’s readiness to adopt self-management strategies 
and treatment outcomes with other measures that are known to predict treatment 
outcomes. Not only will this research uncover the unique variability in treatment 
outcomes that are attributable to individual’s readiness to engage in self-management 
strategies, it will elucidate the clinical utility of stage of change constructs. For 
example, Kerns and Rosenberg (2000) have speculated that their results, indicating 
that progression through the stages of change predicted pain outcomes, might reflect 
psychological treatment promoting beliefs that encourage the use of pain self-
management strategies, such as perceived benefit, and ultimately adherence to these 
strategies. The authors also offer an alternative explanation for these findings, 
suggesting that these changes may reflect increases in self-efficacy. Understanding 
these processes are critical for determining the mechanisms through which readiness 
to engage in pain self-management strategies improve treatment outcomes. However, 
without assessing the relationship between readiness and adherence and the impact of 
other known moderators and mediators on both adherence and treatment outcomes, it 
is unclear how to best improve current treatment. 
 
Third, there is a need to determine the process by which adherence mediates 
individuals readiness and pain outcomes. A number of authors have discussed a 
unique therapeutic benefit from increased readiness to adopt pain self-management 
strategies (Burns et al., 2005; Gersh, Arnold & Gibson, 2011; Glenn & Burns, 2003; 
Kerns & Rosenberg, 2000). Determining the factors underpinning participant’s 
motivation for engaging in and completing treatment is likely to provide a starting 
point for interventions that increase adherence. Based on the recommendations of the 
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motivational model of pain self-management, future research needs to develop 
innovative techniques to assess the bi-directional effects between adherence and the 
perceived benefit of adhering.  
 
Finally, there is a need to systematically assess the variables that influence adherence 
to pain self-management strategies from a theoretical framework. We have seen vast 
improvements in chronic pain treatment as a result of research validating theoretical 
models, such as the fear avoidance model. At present, motivational models are well 
recognised as significant components of treatment efficacy in other fields, such as 
drug and alcohol, but their scientific backing and application in current chronic pain 
treatment are not adequately evaluated (Crombez, Eccleston, Van Damme, Vlaeyen, 
& Karoly, 2012). There is a need to validate the various components of prominent 
motivational models of chronic pain, such as the motivational model of pain self-
management from research in clinical settings (Jensen et al., 2003).  
 
1.10 Aims and hypotheses 
The major aim of this research project is to determine the relevance of the 
transtheoretical model and motivational model of pain self-management to improving 
pain outcomes. To do this, I present two studies. The first study is a meta-analysis and 
systematic review that aims to determine whether motivational interviewing, an 
approach that strives to improve motivation to adopt adaptive behaviour and often 
draws on the transtheoretical model in clinical settings, is effective in improving 
adherence to chronic pain treatments. Furthermore, this study aims to determine 
whether motivational interviewing is associated with improvements in pain outcomes, 
such as pain intensity and physical functioning. It is hypothesised that motivational 
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interviewing approaches are associated with adherence to chronic pain treatments and 
pain outcomes, such as pain intensity and physical functioning.   
 
The second study is an empirical study that aims to determine whether constructs 
from the transtheoretical model and motivational model of pain self-management can 
predict adherence to pain self-management strategies, and in doing so, predict better 
functional outcomes for patients. Specifically, the second study aims to: 1) determine 
whether motivation to change pain related behaviour is associated with adherence to 
self-management strategies. 2) determine whether motivation to change pain related 
behaviour predicts adherence to self-management strategies over and above other 
relevant variables, such as self-efficacy; 3) determine whether adherence to 
self-management strategies mediates the relationship between individuals’ motivation 
to change pain related behaviour and pain outcomes; and 4) explore the relationship 
between individual’s beliefs about the perceived benefit in using self-management 
strategies and adherence to these strategies as no empirical investigation of this 
relationship has been carried out to date. In order to determine the current study aims, 
this study will also confirm past findings that: a) a multidisciplinary pain management 
program that promotes pain self-management strategies leads to improvements in pain 
outcomes; b) adherence predicts improvements in pain outcomes. 
 
In accordance with prior research and the second study’s aims, it is hypothesised that: 
1) the ADAPT program will lead to improvements in pain and cognitive process 
outcomes; 2) adherence to pain self-management strategies during the ADAPT 
program will predict improvements in pain outcomes; 3) readiness to adopt pain self-
management strategies will predict adherence to these strategies; 4) readiness to adopt 
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pain self-management strategies will predict adherence to these strategies over and 
above other relevant variables, such as self-efficacy; 5) adherence to pain 
self-management strategies will mediate the relationship between individuals’ 
readiness to adopt pain self-management strategies and pain outcomes; 6) individual’s 
beliefs about the perceived benefit in using pain self-management strategies will 
predict adherence to these strategies; and 7) adherence to pain self-management 
strategies will predict individual’s perceived benefit in using these strategies.   
 
1.11 Outcomes and significance 
The findings from this study will inform what constructs may mediate patient benefits 
from adherence to pain-self management strategies so that a targeted approach to 
maximising patient outcomes may be identified. Furthermore, it will inform the 
current motivational model of pain self-management. If motivation to change pain-
related behaviours predicts adherence over and above other relevant measures, such 
as self-efficacy, motivational enhancement strategies may improve adherence to pain-
management programs in order to maximise treatment-related gains. On the other 
hand, if other recognised cognitive process measures, such as self-efficacy are better 
predictors of adherence, interventions to improve patients’ cognitive processes may 
have more potential to increase patient outcomes from pain self-management 
programs.  
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CHAPTER 2 
 
The Efficacy of Motivational Interviewing in adults with Chronic Pain: A Meta-
Analysis and Systematic Review 
The following chapter is a replication of material contained in the paper:  
Alperstein, D., & Sharpe, L. (2015). The Efficacy of Motivational Interviewing in 
adults with Chronic Pain: A Meta-Analysis and Systematic Review. The Journal of 
Pain. 
 
Appendix A contains the peer-reviewed publication. 
 
Minor formatting changes have been made to the paper to ensure consistency with 
other chapters in this thesis. 
 
Dion Alperstein and Louise Sharpe together developed the concept and protocol for 
this meta-analysis. Dion Alperstein conducted the search, and both Dion Alperstein 
and Louise Sharpe reviewed abstracts and full-text documents that were retrieved. 
Dion Alperstein conducted the analyses, with the help of Louise Sharpe and both 
authors contributed to the interpretation of the findings. Dion Alperstein wrote the 
first draft of the manuscript and Louise Sharpe contributed to changes in the 
manuscript.  
 
Dion Alperstein Signature:          Date:  
 
Louise Sharpe Signature:      Date:  
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2.1 Introduction 
Although there are a myriad of available treatments for chronic pain (Chilton, Pires-
Yfantouda & Wylie, 2012; Novy, 2004; Williams, Eccleston & Morley, 2012), the 
effect sizes associated with these treatments are small and likely to be sub-optimal. 
One factor that may limit the efficacy of available treatments is low rates of 
adherence (Butow & Sharpe, 2013). It is estimated nearly one third of patients with 
chronic pain fail to adhere to prescribed medication (Broekmans, Dobbels, Milisen, 
Morlion & Vanderschueren, 2009) and adherence rates for other treatments are also 
low. For example, 30% of patients failed to adhere to physical therapy (Kolt & 
McEvoy, 2003) and only 50% to a cognitive behavioural rehabilitation (Nicholas et 
al., 2012; Nicholas et al., 2014).  
 
Although not widely studied (Broekmans et al., 2009), adherence may be important to 
improving patient outcomes. While there is insufficient evidence to conclude whether 
adherence to medication is associated with outcomes (Broekmans, 2009) non-
adherence to physical therapies was consistently shown to be associated with poorer 
outcome in a recent review (Jack, McLean, Moffett & Gardiner, 2010). Further, a 
recent study to investigate adherence to a psychosocial program and outcomes, found 
strong positive relationships between adherence and outcome at the end of a pain 
management program (Nicholas et al., 2012). Furthermore, those who consistently 
adhered during the intervention not only benefited more in the short term, but they 
improved further over the following year (Nicholas et al., 2014). Clearly, improving 
adherence is likely to improve patient outcomes. 
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Motivational interviewing (MI) is a person-centered approach that aims to resolve 
individual’s ambivalence about behavior change by strengthening their own 
motivation and commitment to change (Miller & Rollnick, 2012). MI was initially 
developed to improve adherence to drug and alcohol treatment (Miller, 1983), but has 
been extended to a range of different indications, such as diet, exercise and sexual 
health (Burke, Arkowitz & Menchola, 2003; Lai, Cahill, Qin & Tang, 2010). In 
clinical settings, MI frequently draws upon the transtheoretical model (TTM) of 
behaviour change (Prochaska & DiClemente, 1986) as a conceptual model, which 
suggests that individuals go through the following stages of change before adopting 
and maintaining new behaviours: precontemplation, contemplation, preparation, 
action and maintenance. Central to this model is the notion that optimal treatment is 
most effective when individuals are at least in the preparation or action phase for 
change (Prochaska, DiClemente & Norcross,1993). Hence, MI is used to try and help 
patients achieve an optimal stage of change to promote treatment adherence and 
ultimately efficacy.  
 
Meta-analyses have demonstrated that there is support for MI in some areas, such as 
drug and alcohol, diet and exercise, but not other areas, such as HIV-risk behaviours 
(Burke, Arkowitz & Menchola, 2003; Lai et al., 2010). Although the use of MI for 
chronic pain is frequently advocated (Hammond, 2003; Jones, Burckhardt & Bennett, 
2004; Sanders, Donahue & Kerns, 2007), only one systematic review (Chilton, Pires-
Yfantouda & Wylie, 2012) and one summary paper (Dorflinger, Kerns & Auerbach, 
2013) have examined the effectiveness of MI with chronic pain populations. Both 
papers acknowledge the lack of empirical research and conclude that MI is a 
promising approach in promoting adherence to available treatments for chronic pain 
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conditions. However, one of the reviews assessed the effect of MI in both acute and 
chronic pain conditions and included non-randomized controlled trials (Chilton, Pires-
Yfantouda & Wylie, 2012). In the other review, half of the included studies in the 
summary paper assessed approaches that were designed to increase adherence but 
were not based on MI principles (Dorflinger, Kerns & Auerbach, 2013). Further, 
neither review provided a meta-analysis. The present study aims to address these 
limitations in the current literature by conducting a meta-analysis of randomized 
controlled trials that examine the efficacy of MI approaches to increase adherence to 
treatments in the chronic pain population. This meta-analysis will examine the 
efficacy of MI on the primary outcome of adherence to treatment. In addition, we will 
investigate the efficacy of MI on the secondary outcomes of pain intensity and 
function.    
 
2.2 Methods 
2.2.1 Search strategy 
A literature search was performed on the following electronic databases on February 
11, 2014: PsychINFO (1806-February 11, 2014); MEDLINE (1946- February 11, 
2014); EMBASE (1947- February 11, 2014); CINAHL (1981- February 11, 2014). In 
addition, we applied the ancestry method by hand searching the reference lists of 
empirical articles and relevant review papers (Cooper, 1982). The search terms used 
in each database are listed in Table 1. The search terms used in each database varied 
slightly so that they mapped to database-specific subjects headings. The search was 
constrained to English text. A detailed overview of the article retrieval process, 
including exclusion criteria at each stage of the search, is displayed in Figure 2.The 
initial search retrieved 1180 studies and 133 of these were duplicates, which were 
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excluded, leaving 1047 studies. The remaining studies were initially screened by title 
and abstract by one author (DA). A second author (LS) screened 10% of the titles and 
abstracts in order to reduce bias in the selection procedure and to ensure inter-rater 
reliability. Inter-rater reliability was determined using Kappa statistic and was rated as 
excellent (kappa= 0.94). All papers where either reviewer thought the full text should 
be retrieved, were read in detail. In total, 974 studies were excluded by title or 
abstract, leaving 73 studies where the full text was retrieved.  
Table 1  
Search terms for each database in the literature search 
 
PsychINFO: 
(chronic pain OR intractable pain OR fibromyalgia OR arthritis) AND (motivational interviewing OR 
motivational enhancement OR motivati* OR transtheoretical OR trans-theoretical OR stages of change) 
AND (randomized controlled trial OR controlled clinical trial OR randomised controlled trial OR clinical 
trial OR clinical trials).  
 
MEDLINE: 
(chronic pain OR intractable pain OR pain, intractable OR fibromyalgia OR arthritis) AND (motivational 
interviewing OR motivational enhancement OR motivati* OR transtheoretical OR trans-theoretical) AND 
(randomized controlled trial OR controlled clinical trial OR randomised controlled trial).  
 
EMBASE: 
(chronic pain OR intractable pain OR pain, intractable OR fibromyalgia OR arthritis) AND (motivational 
interviewing OR motivational enhancement OR motivati* OR transtheoretical OR trans-theoretical) AND 
(randomized controlled trial OR controlled clinical trial OR randomised controlled trial).  
 
CINAHL: 
(chronic pain OR intractable pain OR fibromyalgia OR arthritis) AND (motivational interviewing OR 
motivational enhancement OR motivati* OR transtheoretical OR transtheoretical stages of change 
model OR trans-theoretical OR stages of change) AND (randomized controlled trial OR controlled 
clinical trial OR randomised controlled trial OR clinical trial OR clinical trials OR cochrane library).  
 
 
These 73 studies were read in detail and a further 66 studies were excluded at this 
stage, leaving seven relevant articles to be included in the final review. The second 
reviewer also screened the full text of the chosen studies. There were no discrepancies 
in the inclusion or exclusion of studies and the final list of seven studies make up the 
current review. The reasons that studies were not included were: participants did not 
have a chronic pain condition (n=198); the study did not use MI (n=603); the paper 
was not a primary peer reviewed study (n=225); MI was not controlled (n=11); the 
study was not an RCT (n=3).  
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Fig.2. Flow chart of article retrieval process 
 
Papers identified via electronic database searching 
PsychINFO (03/02/14); MEDLINE (03/02/14); EMBASE 
(03/02/14); CINAHL (03/02/14). 
N = 1178 
 
Papers identified via searching the reference list of 
papers and relevant reviews 
N = 2 
 
Total papers identified in initial search 
N = 1180 
 
Deleted Duplicates (-133) 
Papers retrieved for abstract reading 
 
 
(n=1047) 
 
Papers retrieved for full-text screening 
 
(n=73) 
Final sample of included papers 
 
(n= 7) 
Papers excluded after abstract screening 
- Reasons for exclusion: 
 
Not adults with chronic pain (n=198) 
Not a primary peer reviewed study (n=225) 
No active TTM-based therapy (n=551) 
 
 
(n=974) 
Papers excluded after full-text screening 
- Reasons for exclusion: 
 
No active TTM-based therapy (n=52) 
Not RCT or Quasi RCT (n=3) 
TTM-based therapy not controlled (n=11) 
 
(n=66) 
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2.2.2 Inclusion/ Exclusion criteria 
2.2.2 (a) Types of studies 
This review considered all studies that were RCTs that compared individuals with 
chronic pain conditions receiving MI with an inactive control group, such as an 
attention, placebo or wait-list control group. RCTs were also considered that 
compared individuals with chronic pain conditions receiving MI in conjunction with 
another intervention (e.g. physical therapy or opioid medication), as long as any 
additional intervention was controlled for in the other arm, allowing the unique 
contribution of MI to be determined. Studies were excluded if they examined MI but 
did not control for other active treatments. The aim of the study had to include a 
treatment goal of increased adherence to treatment for chronic pain or improvements 
in pain intensity or physical functioning/ disability.  
 
2.2.2 (b) Types of participants 
Participants had to be adults (18 years of age or older) with a benign chronic pain 
condition, in which pain was reported lasting more than three months. Studies were 
excluded if they examined participants with acute pain, pain related to cancer or pain 
as a result of surgery. 
 
2.2.2 (c) Types of interventions 
Studies were only included that used MI approaches based on MI principles (Miller & 
Rollnick, 2012). That is, the overarching aim of MI was to improve individual’s 
readiness to change their behavior by endorsing a person-centered approach to 
resolving their ambivalence about behavior change and strengthening their own 
motivation and commitment to change, resulting in increased adherence to available 
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treatment. In some studies, MI was used as a preparation for treatment. For example, 
MI was used to increase individual’s readiness to change pain related behaviour with 
the aim of increasing adherence to a multidisciplinary pain management program. In 
other studies, MI was used to increase adherence to a treatment that was already 
available but was poorly adhered to, such as anti-rheumatic drugs or physical 
exercise. Therefore, motivational approaches, such as compliance counseling and 
mental contrasting, that were not based on MI principles were not included. Although 
MI is really more a therapeutic style or approach than necessarily a discrete 
intervention, all the trials included in this meta-analysis separated MI from any other 
intervention for the research context. Studies were included regardless of the dose of 
MI (i.e. the number and length of sessions), or how the MI was administered (e.g. 
face to face or by telephone).  
 
2.2.3 Outcome measures 
2.2.3 (a) Primary outcomes 
The primary outcome of this review was adherence to prescribed treatment for pain, 
at post-treatment and at six-month follow up. We included any measure of adherence 
that was provided by the authors. Adherence measures included: log books that were 
used to document the duration and intensity of physical activity in studies that aimed 
to increase physical exercise; participation rates in a study that used MI as a means of 
increasing adherence to a pain management program; the Freiburger Questionnaire on 
Physical Activity in a study that aimed to increase physical exercise; the Compliance 
Questionnaire Rheumatology to assess adherence to anti-rheumatic drugs.    
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2.2.3 (b) Secondary outcomes 
The secondary outcomes were symptoms of pain intensity and physical functioning/ 
disability at post-treatment and six-month follow up. Pain intensity measures were 
standardized questionnaires or visual analogue scales that assessed the individual’s 
reported level of pain severity and included: Brief Pain Inventory; Visual Analogue 
Scale; Von Korff-Scheme. Physical functioning measures were standardized 
questionnaires that assessed participant’s level of physical functioning or disability 
and included: Fibromyalgia Impact Questionnaire – Physical Impairment; Hannover 
Functional Disability Questionnaire; Rolland-Morris Disability Questionnaire; Health 
Assessment Questionnaire Disability Index.  
 
2.2.4 Quality assessment 
The quality of studies was rated using the Quality Rating Scale (Yates, Morley, 
Eccleston & Williams, 2005). This scale was developed specifically for rating the 
quality of psychological trials for pain and contains two subscales: treatment quality 
and quality of study design and method. The treatment quality scale contains ratings 
on a range of variables, including: treatment content and setting; treatment duration; 
use of a manual; adherence to a manual; therapist training; and patient engagement. 
The quality of study design and method contains ratings on a range of variables 
relating to: the sample criteria; attrition; sample characteristics; steps in minimizing 
biases; justification, validity and reliability of outcomes; follow up measures; 
statistical analyses; and control group. Higher scores on the Quality Rating Scale 
indicated higher treatment and methodological quality. The two authors (DA and LS) 
rated all included studies and the inter-rater reliability was measured by the intra-class 
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correlation co-efficient using absolute agreement. The reported quality score was 
determined by consensus.  
 
2.2.5 Data extraction 
In order to determine treatment effects on the primary and secondary outcomes, 
standardized mean differences were extracted from each paper. This was achieved by 
extracting the means, standard deviations and the number of participants in each 
group (MI vs control) from studies at baseline, at the conclusion of treatment and up 
to six-months post treatment. Where these statistics were not reported, or baseline 
data were not relevant to the outcome, such as the measurement of treatment 
adherence, standardized mean differences were determined by extracting other 
reported statistics. The authors from two studies were contacted in order to collect 
data that was not reported so that standardized mean differences could be calculated. 
The list of studies used in the analysis and the specific methods used to extract data 
from each study are provided in Supplementary Table 1.  
 
Some studies used more than one measure of adherence, pain intensity or physical 
functioning. Including multiple measures from a single study would bias our findings 
in favour of finding a treatment effect. Thus, we chose a single measure from each 
study based on the reliability and validity of the measure and by determining the most 
conceptually valid measure for assessing the effect of MI on adherence and 
subsequent changes in pain intensity and physical functioning. There was no 
disagreement between the authors in the selection of outcome measures during the 
decision making process.  
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2.2.6 Analytic method 
A meta-analysis was carried out where four or more studies had available data on any 
primary or secondary outcome. In the case that there was insufficient data to conduct 
a meta-analysis, a qualitative analysis of data is reported. All meta-analyses were 
completed using Comprehensive meta-analysis, version 2 (Borenstein, Hedges, 
Higgins & Rothstein, 2005). Separate effect size estimates were calculated for 
continuous measures of adherence, pain intensity and physical functioning; at post-
treatment and six month’s follow-up. Effect sizes were calculated using Hedges’s g 
and its 95% confidence interval. Hedges’s g, a variation of Cohen’s d, was used to 
correct for biases associated with small sample size (Hedges & Olkin, 1984). The 
magnitude of Hedges’s g can be interpreted as follows: small = 0.2, medium = 0.5, 
and large = 0.8 (Cohen, 1988). An assessment of heterogeneity was carried out for 
each meta-analysis to determine whether effect size estimates differed by more than 
one would expect due to chance. Heterogeneity was assessed using the Q statistic. For 
adherence, heterogeneity was evident across studies and to account for the assumption 
that the difference between study outcomes was greater than chance a random-effects 
model was used to calculate effect size estimates. For the remaining outcomes, there 
was no evidence of heterogeneity. As such, fixed-effects models are presented as it is 
assumed that effect size estimates only differ by sampling error (Hedges & Vevea, 
1998; Lipsey & Wilson, 2000). To account for potential publication bias, the fail-safe 
N was calculated. The fail-safe N is considered a good measure of publication bias 
and provides an estimate of the number of studies with a null finding that would be 
required before the P value for the meta-analysis rises above 0.05.  Thus, the larger 
the fail-safe N the less likely publication bias is present.  
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2.3 Results 
2.3.1 Characteristics of the study sample 
A total of 7 studies were included in the meta-analysis with a total of 962 chronic pain 
participants (Ang et al., 2013; Basler et al., 2007; Habib, Morrissey & Helmes, 2005; 
Leonhardt et al., 2008; Miller, Cano & Wurm, 2013; Vong, Cheing, Chan, So & 
Chan, 2011; Zwikker et al., 2012). The key features of the included studies are shown 
in Table 2. Our analysis included studies with different types of chronic pain 
conditions, including 3 (n=484 participants) with chronic lower back pain, 1 (n=216 
participants) with fibromyalgia, 2 (n=125 participants) with heterogeneous chronic 
pain conditions, and 1 (n=137 participants) with rheumatoid arthritis. All studies had 
an inactive control group, such as an attention control or placebo group. In 6 of the 7 
studies, MI was delivered in conjunction with another treatment, where the additional 
intervention was controlled for in the other arm, allowing the unique contribution of 
MI to be determined. Of the 6 studies that had an adjunct treatment, 2 were 
physiotherapy treatments, 1 was supervised exercise, 2 were the dissemination of 
educational brochures or guidelines and 1 was an oral history interview. Individual 
MI was delivered in 6 of the 7 studies and the remaining study used a group format. 
 
2.3.2 Quality of included studies 
The inter-rater reliability for the total quality rating score, treatment quality score and 
quality of study design and methods score was determined by the intra-class 
correlation co-efficient using absolute agreement and was 0.901, 0.968 and 0.873 
respectively. The total quality rating score of each study are shown in Table 3. The 
mean total quality rating score for the 7 studies was 22.14 (SD = 7.36) out of a 
possible 35, ranging from 12 to 30. The mean subscale scores were 5.29 (SD = 1.80) 
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Table 2 
Characteristics of studies included in the analysis 
 
Study 
(Author, Year) 
Chronic Pain 
Condition 
TTM Based Intervention Control  
Intervention 
Common Intervention TTM Therapist 
Ang, 2013 Fibromyalgia MI was delivered via 6 x 
telephone calls over a 12-
week period (n=107). 
Education intervention was 
delivered via 6 x telephone calls 
over a 12-week period (n=109). 
Supervised exercise prescription and 
exercise training. 
Health 
practitioner or 
health educator 
Basler, 2007 LBP 10-minute TTM-based 
standardized counselling 
prior to each physiotherapy 
session (n=86). 
Placebo ultrasound therapy with 
an inactivated device (n=84). 
10 x 20-minute standardized individual 
physiotherapy sessions over 5 weeks 
with exercises for homework. 
Physiotherapists 
Habib, 2005 Chronic pain 1 x 1-1.5 hour MI-based 
assessment interview and 1 
x 1.5 hour MI-based 
feedback interview (n=39).   
1 x 1-1.5 hour non-MI based 
standard pain clinical assessment 
interview and 1 x 1 hour non- MI 
based feedback interview (n=39).   
Multidisciplinary Pain management 
workshops were provided following 
the study intervention.   
Psychologists 
Leonhardt, 2008 LBP 1 -3 TTM-based 
motivational counseling 
sessions of maximum of 15-
20 minutes (n=101). 
General practitioner’s delivered 
guidelines with no training. 
Known to have no effect (n=104). 
2 hour guidelines training. Nurses 
Miller, 2013 Chronic pain MI based feedback of the 
oral history interview 
(n=24). 
Educational (oral and written) 
feedback session focusing on the 
gate control theory of pain 
(n=23). 
Oral history interview regarding 
marital relationship and conversation 
about coping with pain. 
Doctoral level 
psychologists 
Vong, 2011 LBP MET was delivered during 
physical therapy sessions 
(n=45). 
Usual communication skills 
consistent with clinical practice.  
(n=43). 
10 x 30-minute physical therapy 
sessions were delivered over 8 weeks 
with prescribed exercise, stretching 
and strengthening homework tasks. 
Physical therapist 
Zwikker, 2014 Rheumatoid 
Arthritis  
2 x MI-based group sessions 
of 5-7 people were 
conducted 1 week apart 
(n=57). 
Control group was recipient of 
conjunct treatment (n=60). 
Dissemination of brochures about the 
adherence to disease-modifying anti-
rheumatic drugs. 
Pharmacists 
 
MI, Motivational interviewing; MET, Motivational enhancement treatment; LBP, Lower back pain; TTM, Transtheoretical model
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out of 9 (range 3-8) for treatment quality. Across studies, ratings on the treatment 
content and setting and treatment duration variables were excellent, indicating that 
studies provided a clear rationale for the treatment and an adequate description of its 
content and reported the total treatment duration. Ratings on the therapist training was 
generally good, though two studies failed to report on whether the therapist had been 
appropriately trained for the relevant procedures in the trial. Ratings on the use and 
adherence to a manual and patient engagement was generally poor, with only two of the 
seven studies reporting a treatment manual that describes the active components of 
treatment and only two studies reporting evidence that patients actively engaged in the 
treatment. The mean subscale scores were 16.86 (SD = 6.39) out of 26 (range 8-22) for 
quality of study design and methods. Across studies, ratings on the sample criteria, 
attrition, justification, validity and reliability of outcomes, statistical analysis and use of 
a control group were excellent. Ratings on the sample characteristic, steps in 
minimizing biases and reporting of follow up measures were mixed with four of the 
seven studies rated as excellent but three of the studies being rated as poor. The mean 
score for excellent, average and poor trials in the validation sample of the quality rating 
scale was 22.7 (SD = 1.95), 18.71 (SD = 2.25) and 12.10 (SD = 3.17) respectively 
(Yates, Morley, Eccleston & Williams, 2005). Hence, the studies included in this meta-
analysis correspond to excellent quality trials.  
 
2.3.3. Effects of MI for patients with chronic pain 
The statistical analysis by article for primary and secondary outcomes is shown in Table 
3. 
 
 65 
Table 3 
Statistical analysis by article for primary and secondary outcomes 
Reference 
(author, 
year) 
Adherence outcome 
and measure 
Pain intensity 
outcome and measure 
Physical Functioning 
outcome and measure 
Meta-analysis 
outcome 
Hedges’s g 95% 
Confidence 
interval 
p-Value 
 
* Sig 
Quality 
rating 
Scale 
(Descriptor) 
Ang,  
2013 
Adherence to 
prescribed physical 
activity measured by  
the Community Health 
Activities Model 
Program For Seniors  
Questionnaire 
Pain intensity measured 
by the Brief Pain 
Inventory. 
Physical functioning 
measured by the 
Fibromyalgia Impact 
Questionnaire – 
Physical Impairment  
Baseline–post: 
Adherence 
Pain intensity 
Functioning 
 
Baseline–FU: 
Adherence 
Pain intensity 
Functioning 
 
.339 
.099 
- 
 
 
.123 
.000 
.063 
 
0.071-0.607 
-0.167-0.365 
- 
 
 
-0.144-0.389 
-0.266-0.266 
-0.203-0.328 
 
0.013* 
0.466 
- 
 
 
0.367 
1.000 
0.644 
30 
(Excellent) 
Basler, 
2007 
Adherence to 
prescribed physical 
activity (average 
duration of physical 
activity per day) 
measured by an 
exercise log book.  
 
Not measured Functional capacity 
measured by the 
Hannover Functional 
Disability Scale 
Baseline–post: 
Adherence 
Pain intensity 
Functioning 
 
Baseline–FU: 
Adherence 
Pain intensity 
Functioning 
 
.177 
- 
.145 
 
 
.112 
- 
.129 
 
-0.146-0.499 
- 
-0.155-0.444 
 
 
-0.210-0.434 
- 
-0.170-0.429 
 
0.283 
- 
0.344 
 
 
0.495 
- 
0.397 
28 
(Excellent) 
Habib, 
2005 
Adherence to pain 
management program 
measured by 
attendance rates to the 
pain management 
program 
 
 
 
 
 
 
Not measured Not measured Baseline–post: 
Adherence 
Pain intensity 
Functioning 
 
Baseline–FU: 
Adherence 
Pain intensity 
Functioning 
 
.649 
- 
- 
 
 
- 
- 
- 
 
 
 
 
 
 
0.177-1.120 
- 
- 
 
 
- 
- 
- 
 
 
0.007* 
- 
- 
 
 
- 
- 
- 
 
13 
(Poor) 
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Reference 
(author, 
year) 
Adherence outcome 
and measure 
Pain intensity 
outcome and measure 
Physical Functioning 
outcome and measure 
Meta-analysis 
outcome 
Hedges’s g 95% 
Confidence 
interval 
p-Value 
 
* Sig 
Quality 
rating 
scale 
Leonhardt, 
2008 
Adherence to 
prescribed physical 
activity measured by the 
Freiburger 
Questionnaire on 
Physical Activity 
Pain intensity measured 
by the Von Korff-
scheme 
Physical functioning 
measured by the 
Hannover Functional 
Disability Questionnaire 
Baseline–post: 
Adherence 
Pain intensity 
Functioning 
 
Baseline–FU: 
Adherence 
Pain intensity 
Functioning 
 
- 
- 
- 
 
 
.104 
.005 
.173 
 
- 
- 
- 
 
 
-0.169-0.377 
-0.305-0.315 
-0.101-0.447 
 
- 
- 
- 
 
 
0.454 
0.975 
0.216 
20 
(Average) 
Miller, 
2013 
Not measured 
 
Pain intensity measured 
by the Brief Pain 
Inventory 
Not measured Baseline–post: 
Adherence 
Pain intensity 
Functioning 
 
Baseline–FU: 
Adherence 
Pain intensity 
Functioning 
 
- 
.566 
- 
 
 
- 
.448 
- 
 
 
- 
-0.014-1.146 
- 
 
 
- 
-0.128-1.024 
- 
 
 
- 
0.056 
- 
 
 
- 
0.127 
- 
 
12 
(Poor) 
Vong, 
2011 
Adherence to 
prescribed physical 
activity measured by an 
exercise log book.  
 
Pain intensity measured 
by a Visual Analogue 
Scale 
Physical functioning 
measured by the 
Rolland-Morris Disability 
Questionnaire  
Baseline–post: 
Adherence 
Pain intensity 
Functioning 
 
Baseline–FU: 
Adherence 
Pain intensity 
Functioning 
 
1.216 
.132 
.152 
 
 
1.200 
.343 
.340 
 
0.731-1.701 
-0.314-0.577 
-0.294-0.598 
 
 
0.715-1.684 
-0.105-0.791 
-0.108-0.788 
 
0.000* 
0.562 
0.504 
 
 
0.000* 
0.134 
0.137 
24 
(Excellent) 
Zwikker, 
2014 
Adherence to 
prescribed medication 
measured by the 
Compliance 
Questionnaire 
Rheumatology 
 
Pain intensity measured 
by a Visual Analogue 
Scale 
Physical functioning 
measured by the Health 
Assessment 
Questionnaire Disability 
Index 
Baseline–post: 
Adherence 
Pain intensity 
Functioning 
 
Baseline–FU: 
Adherence 
Pain intensity 
Functioning 
 
-.034 
.488 
.142 
 
 
-.141 
.122 
.000 
 
-0.398-0.331 
-0.225-0.509 
0.179-1.132 
 
 
-0.508-0.226 
-0.247-0.491 
-0.366-0.366 
 
0.857 
0.011* 
0.448 
 
 
0.450 
0.517 
1.000 
28 
(Excellent) 
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2.3.3 (a) Analysis of the primary outcome: Adherence 
Five studies with 631 participants had available data on adherence to treatment from baseline 
to post intervention. The Q statistic revealed heterogeneity between the studies (Q = 19.186, 
p = 0.001), hence we used a random effect model. Our analyses (Figure 3) revealed that there 
was a small to moderate overall effect of MI on adherence to treatment from baseline to post 
intervention (Hedge’s g = 0.441, 95% CI: 0.078-0.80, z = 2.384, p = 0.017). This effect size 
corresponds to a fail-safe N of 27 studies (z = 4.912).  
 
There were also five studies with 757 participants that reported data on adherence to 
treatment from baseline to six-month follow-up. In these studies there was significant 
heterogeneity, as revealed by the Q statistic (Q = 20.629, p < 0.0005) In contrast to the short-
term results, there was no significant overall effect of MI on adherence to treatment at six-
month follow-up (Hedge’s g = 0.245, 95% CI: -0.091-0.581, z = 1.429, p = 0.153). Hence, 
the impact of MI on adherence does not appear to be observed at six months’ follow-up. 
 
 
Fig.3. Forest plot of the effect estimates (Hedges’s g) of motivational interviewing on adherence to 
treatment from baseline to post chronic pain treatment. 
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2.3.3 (b) Analysis of the secondary outcomes: Pain intensity and physical functioning 
There was sufficient data from four studies with 449 participants to analyse the impact of MI 
on the change in pain intensity from baseline to post intervention (Figure 4). In contrast to the 
analyses for adherence, the analyses revealed homogeneity across studies (Q = 4.221, p = 
0.239), hence we used a fixed effects model. There was a significant, small to moderate 
overall effect of MI on pain intensity reduction from baseline to post chronic pain treatment 
(Hedge’s g = 0.270, 95% CI: 0.040-0.500, z = 2.298, p = 0.022). However, this effect should 
be interpreted within the context of a fail-safe N of only 5 studies (z = 2.884). There were 
also five studies with 610 participants that had data available on the change in pain intensity 
following MI from baseline to six-month follow-up. The effect across these studies was also 
homogenous (Q = 3.466, p = 0.483). The short-term outcomes on pain intensity were not 
replicated in these analyses, which were not significant (Hedge’s g = 0.100, 95% CI: -0.058-
0.259, z = 1.243, p = 0.214).  
 
 
 
 
 
 
 
 
 
 
 
Fig.4. Forest plot of the effect estimates (Hedges’s g) of motivational interviewing on pain intensity 
reduction from baseline to post chronic pain treatment. 
 
 
Unfortunately, only three studies had available data on physical functioning at post-treatment, 
and therefore it was not possible to analyse these data quantitatively. The three studies 
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(Basler et al., 2007; Vong, Cheing, Chan, So & Chan, 2011; Zwikker et al., 2012) reported 
outcomes on physical functioning at post treatment for 170, 76 and 113 participants 
respectively. There was no significant effect of MI on physical function from baseline to post 
intervention in any of the three studies.   
 
There were, however, 5 studies reporting the outcome for 779 participants on physical 
functioning from baseline to six-month follow-up and the results confirmed the short-term 
outcomes. For physical function, there was homogeneity across studies (Q = 1.663, p = 
0.797). Therefore, for this analysis we used a fixed effects model, indicating that there was no 
significant overall effect of MI on physical functioning at six month’s follow-up (Hedge’s g 
= 0.124, 95% CI: -0.016-0.265, z = 1.733, p = 0.083).  
 
2.4 Discussion 
The primary aim of this meta-analysis and systematic review was to examine the effect of MI 
on adherence to prescribed chronic pain treatment. The secondary aim was to examine the 
effect of MI on pain intensity and physical function. The major finding from this meta-
analysis and systematic review was that MI significantly increased adherence to prescribed 
treatments in the short term, with small to moderate effects sizes. However, the impact of MI 
on adherence was not maintained at six-month follow up. We also confirmed that MI resulted 
in significant short term reductions in pain intensity, which were again not observed at six-
month follow-up. While it was not possible to conduct a meta-analysis of the short term 
effect of MI on physical functioning, none of the studies found a significant short term effect 
of MI on physical function. Data at six month’s follow-up failed to find an impact of MI on 
physical function. 
 
 70 
While MI resulted in significant improvements on adherence and pain in the short-term, the 
robustness of these findings needs to be interpreted within the context of the limitations of 
this meta-analysis. The main limitation of this meta-analysis is the small number of MI 
studies and the resulting lack of statistical power. For both adherence and pain, our computed 
fail-safe Ns of 27 and 5, respectively are lower than recommended (Rosenthal, 1991). For 
pain, the fail-safe N of 5 clearly indicates that the findings should be interpreted cautiously. 
Given the relatively few studies in this area, the results indicating that MI has a short-term 
impact on adherence are more promising. Nonetheless, the large observed confidence 
intervals for the effect of MI on adherence (Hedge’s g =0.078-0.798) indicates that 
considerably more research is needed before we can confidently conclude that MI 
significantly improves adherence to pain treatments. Hence, it is premature to include MI as 
part of the routine treatment of individuals with chronic pain, although further research 
should be encouraged.  
 
Adherence is known to be under-studied in chronic pain (Butow & Sharpe, 2013). However, 
there were a number of ways in which we could have increased the number of studies 
available for review. Firstly, we could have included a range of designs (e.g. case control 
studies and prospective cohort studies) to increase the available studies. However, these 
designs are far more likely to favour a therapy that is ineffective due to the lack of control. 
Therefore, we decided to limit studies to RCTs, so that we could have more confidence in the 
results. Had we included these studies, we would have at least an additional three studies. 
Notably, of these three studies, all demonstrated the efficacy of MI on adherence, supporting 
the preliminary conclusions offered here (Ang, Kesavalu, Lydon, Lane & Bigatti, 2007; 
Nevedal, Wang, Oberleitner, Schwartz & Williams, 2013; Vriezekolk, Geenen, van den 
Ende, Slot, van Lankveld & van Helmond, 2012). Similarly, many studies that investigate MI 
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compare MI plus some other intervention on a range of outcomes to an unrelated control 
condition (Ehrlich-Jones, Lee, Semanik, Cox, Dunlop & Chang, 2011; Tse, Vong & Tang, 
2013). These studies typically find that the combined treatment is effective on one or more of 
the outcomes (e.g. pain intensity, physical functioning and self-efficacy), including adherence 
(e.g. physical activity). However, it is impossible to determine in these designs whether the 
impact is due to MI or the other active intervention. As such, we decided to be conservative 
and only include studies where any additional intervention was controlled for in the other 
arm, allowing the unique contribution of MI to be determined.  
 
There were two studies that met the inclusion criteria but were nonetheless exceptional and 
are worth discussing as they may have affected the meta-analytic findings. One study was 
included in the final analysis even though data was only provided pretreatment and at follow 
up but not post treatment (Leonhardt et al., 2008). Since this study found that MI was not 
efficacious at six-month follow up, it may have significantly contributed to the findings of 
this meta-analysis, that MI appears to be associated with significant short but not long-term 
improvements in adherence. The other study that was included was the only study that did 
not assess the effect of MI on adherence, only pain intensity (Miller, Cano & Wurm, 2013). 
Furthermore, it was also the only study that assessed the effect of MI in a couples setting, as 
opposed to an individual setting. For these reasons, it could be argued that this study should 
also not be included in the final analysis. To account for either of these possibilities we ran 
the analysis with and without these studies to see if there would be any changes in findings 
but the results were unchanged.  
 
In the literature on improving adherence, there are also a number of other treatments that aim 
to improve motivation, such as motivational programs (Friedrich, Gittler, Halberstadt, 
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Cermak & Heiller, 1998; Friedrich, Gittler, Arendasy & Friedrich, 2005), message framing 
(Janke, Spring & Weaver, 2011), mental contrasting (Christiansen, Oettingen, Dahme & 
Klinger, 2010) and compliance counseling (Jamison, Ross, Michna, Chen, Holcomb & 
Wasan, 2010). We decided to only include studies where the intervention was based on the 
principles of MI, given the fundamental differences in treatment modes and the strong 
empirical support for MI approaches in other areas of psychology (Hettema, Steele & Miller, 
2005; Miller & Rollnick, 2012). The advantage of this method is that one is examining the 
impact of a clearly articulated therapeutic approach on the variables of interest. However, it is 
possible that there are other approaches to improving motivation. Some studies have 
supported motivational programs, compliance counseling, message framing and mental 
contrasting. However, in each of these areas there are only one or two studies and the results 
are mixed (Chilton, Pires-Yfantouda & Wylie, 2012). Future research should compare 
different methods of enhancing motivation to try and determine the most efficacious 
methods.  Nonetheless, as a result of the small number of studies included in this review, we 
were unable to conduct a moderator analysis. This is particularly relevant to the study of MI 
on adherence to pain treatments.  
 
Some could argue that using functional outcomes, such as pain and disability is not 
appropriate given that the primary target of MI is to improve adherence.  However, we 
disagree for two reasons. The first is that adherence is essentially only an important outcome 
if it translates into better outcomes for patients in important end-points, such as pain and 
disability (which are typically used in reviews of the efficacy of treatments). Second, it is 
possible that the association between adherence and outcome noted in previous studies 
(Nicholas et al., 2012; Nicholas et al., 2014) is not a causal one. That is, it may be that people 
who benefit more from the intervention, adhere more because of this perceived benefit rather 
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than the fact that adherence promotes more benefit. Studies that manipulate adherence and 
are able to show gains in important functional outcomes can provide more evidence of the 
direction of causality.  
 
Despite these limitations, this is the first review to assess the short and long term efficacy of 
MI on adherence to prescribed treatment for pain, and improvements in pain intensity and 
physical functioning among individuals with chronic pain. Furthermore, the use of strict 
inclusion and exclusion criteria to not only maximize the homogeneity of the included studies 
but to ensure studies that controlled for the effects of MI were included, thereby reducing the 
chances of reporting biased findings. Thus, this review builds upon prior reviews that did not 
adequately differentiate between acute and chronic pain conditions, included studies that did 
not adequately control for MI or included studies that were designed to motivate clients to 
adhere to chronic pain treatments, that were not based on MI principles (Chilton, Pires-
Yfantouda & Wylie, 2012; Dorflinger, Kerns & Auerbach, 2013). 
 
Currently, there is insufficient evidence to show that these improvements in adherence 
translate into gains in other outcomes, such as pain and physical function. Given that these 
are the primary outcomes of most interventions with which MI is likely to be paired, the real 
test of MIs clinical usefulness will not be based on whether MI can promote adherence, but 
on whether or not adherence to the intervention improves clinically significant outcomes.  
This review has clearly highlighted the need for more research in this area. One recent study 
compared tailored CBT that incorporated an MI approach with standard CBT and found that 
there were no differences between the two groups in participant engagement and adherence 
(Kerns et al., 2014). The authors propose that this null finding may have been due to the 
uncharacteristically high rates of engagement and adherence to treatment in both groups. 
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Nonetheless, engagement and adherence in both groups was significantly associated with 
improved outcomes from pre to post treatment, highlighting the need for further research 
assessing the processes underlying adherence. We were unable to identify any other 
treatments that used MI with CBT based interventions, although one trial is currently ongoing 
(Mertens, Goossens, Verbunt, Köke & Smeets, 2013). We are also unable to determine the 
necessary dosage of MI or whether it is more effective than other approaches to increasing 
adherence. Despite the preliminary nature of these findings, our results confirm that MI is 
likely to improve adherence to treatment in patients with chronic pain, and may have at least 
short-term impacts on pain levels. However, this is an important area for future research, as 
adherence to treatment is increasingly identified as a problem in the area of pain. 
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CHAPTER 3 
 
Predictors of Adherence to Pain Self-Management Strategies in Chronic Pain: 
Motivation to Change Pain Related Behaviour  
 
3.1. Introduction 
Chapter two provided the results of a meta-analysis and systematic review that sought to 
determine whether MI was associated with increased adherence to treatment, experience of 
pain and physical function for patients with chronic pain. The key finding from this review 
was preliminary evidence that MI significantly increased adherence to chronic pain 
treatments in the short term, with small to moderate effect sizes. However, MI did not impact 
on adherence six-months post treatment. The review also demonstrated that MI was 
associated with significant short-term reductions in pain intensity but not at six-months post 
treatment. Finally, while there were not enough studies to assess the effect of MI on physical 
function in the short term, none of these studies found a significant short-term effect of MI on 
physical function. Further, MI was not associated with improvements in physical function at 
six-months follow up. In sum, the review shows that MI is likely to lead to short-term 
improvements in adherence to chronic pain treatment, though it is not clear if this translates 
into pain outcomes.  
 
While the review demonstrated that MI resulted in improved adherence to chronic pain 
treatment, there is insufficient evidence to suggest that short-term improvements in adherence 
translate into gains in other key outcomes, such as pain intensity and physical function. This 
is an important area for future research as the clinical utility of MI in chronic pain treatment 
is dependent on its influence on pain outcomes, not adherence itself. The current study was 
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established to explore the mechanisms through which MI may impact on pain outcomes by 
exploring the relationship between readiness to adopt pain self-management strategies, 
adherence to these strategies and key pain outcomes among individuals with chronic pain 
attending a multidisciplinary pain management program. The study also assessed the impact 
of individual’s perceived benefits of adopting pain self-management strategies and adherence 
to these strategies.  
 
In line with the research conducted by Nicholas and colleagues (2012; 2014) it is 
hypothesised that: 1) the ADAPT program will lead to improvements in pain and cognitive 
process outcomes; and 2) adherence to pain self-management strategies during the ADAPT 
program will predict improvements in pain outcomes. In accordance with the transtheoretical 
model of behaviour change (Prochaska & DiClement, 1984) and the motivational model and 
pain self-management (Jensen, Neilson & Kerns, 2003) it is hypothesised that: 3) readiness to 
adopt pain self-management strategies will predict adherence to these strategies; 4) readiness 
to adopt pain self-management strategies will predict adherence to these strategies over and 
above other relevant variables, such as self-efficacy; 5) adherence to pain self-management 
strategies will mediate the relationship between individuals’ readiness to adopt pain self-
management strategies and pain outcomes; 6) individual’s beliefs about the perceived benefit 
in using pain self-management strategies will predict adherence to these strategies; and 7) 
adherence to pain self-management strategies will predict individual’s perceived benefit in 
using these strategies.   
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3.2 Method 
3.2.1 Participants  
Participants were recruited between August 2014 and September 2015 from an outpatient 
pain management program called ADAPT, which is run by the Pain Management Research 
Institute (PMRI) at the Royal North Shore Hospital in Sydney, Australia. Individual’s 
suitability for the program were assessed as part of a comprehensive multidisciplinary team 
assessment. The inclusion criteria were: a) the individual was aged 18 years or older; b) the 
individual has experienced chronic and persistent pain for at least six months; c) the 
individual is experiencing disability and/or distress due to their pain, characterised by 
significant interference to every day activities despite appropriate treatments; d) the 
individual has developed excessive reliance on pain medication, which is deemed 
insignificantly effective in decreasing pain severity and every day functioning; e) it is not 
deemed appropriate for the individual to trial any further conventional pain relief treatments. 
The exclusion criteria were: a) the individual had a major psychiatric disorder that would 
affect their ability to participate in the program (e.g. suicidal intent or current psychosis); b) 
the individual could not speak or read English well enough to participate in the program; c) 
the individual was only seeking surgical or medical treatments for their pain.  
 
3.2.2 ADAPT program 
Only the key elements of the ADAPT program are provided here as the program has been 
explained in detail previously (Nicholas, 2004). Approximately ten participants attend each 
ADAPT program that runs from 9:00am to 5:00pm, Monday to Friday for three consecutive 
weeks. A clinical psychologist, medical pain specialist, nurse and physiotherapist facilitate 
the program. All interactions between staff and patients are guided by cognitive-behavioural 
principles with the goal of improving disability associated with pain rather than pain relief. 
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Each patient is expected to develop individualised goals, one of which is to gradually reduce 
or cease medication for pain relief.  
 
Participants learn five core pain self-management strategies through interactive educational 
sessions and physical practice. While a full description of the pain self-management 
strategies are described previously (Nicholas et al., 2004), a summary is provided below: 
 
3.2.2 (a) Activity pacing 
Activity pacing involved completing activities based on personalised set goals and then 
regularly raising these goals in a graded manner every two to three days regardless of pain 
(Gill et al., 1988). Individualised goals were initially set by the participant with the guidance 
of staff and were increasingly set by just the participant. Activity pacing was applied to all 
activities that restricted the participant due to pain (such as walking, sitting and standing) and 
daily activity was recorded on worksheets.  
 
3.2.2 (b) Goal setting 
Participants set operationalised activity goals so that the behaviour necessary to meet each 
goal was specific and unambiguous. More physically demanding goals were set each time a 
previous goal had been achieved.  
 
3.2.2 (c) Thought challenging 
Participants were encouraged to identify and record unhelpful thoughts daily, such as 
catastrophising. Once each unhelpful thought was identified and recorded, participants 
recorded challenges to these thoughts by determining a more realistic appraisal of the event 
or alternative and more helpful thoughts. Problem solving methods were frequently applied to 
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generating more helpful thoughts (Nicholas et al, 2004). 
 
3.2.2 (d) Desensitisation (interoceptive exposure) 
Participants used desensitisation or interoceptive exposure to their pain at least three times a 
day for twenty minutes. Participants were encouraged to observe their pain rather than trying 
to control, push it away or escape from it. Instructions for the desensitisation tasks are 
described elsewhere (Nicholas et al., 2004). 
 
3.2.2 (e) Stretch exercises 
Participants were encouraged to complete at least three 15-minute stretch exercise routines 
per day. They were also encouraged to increase stretching exercises following an escalation 
of pain.  
 
3.2.3 Procedure 
All participants attended the ADAPT program following appropriate referrals from medical 
professionals and did not attend for research purposes. The author attained informed consent 
within the first three days of each program commencing. Since all outcome measures used for 
this study were already collected by the PMRI as part of the clinical assessment, ongoing 
treatment and evaluation of the program, participation involved providing informed consent 
to access the already collected information in the form of de-identified data for research 
purposes. Measures of key pain outcomes and cognitive process measures were collected at 
baseline, immediately following the ADAPT program and at one-month follow up. 
Adherence and perceived benefit measures were collected at the end of each week, while the 
readiness measure was completed at baseline. Ethical approval was gained from the Royal 
North Shore Hospital’s Human Ethics Committee and approval documentation is provided in 
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Appendix B.  
 
3.2.4 Measures 
Consistent with prior research conducted with the ADAPT program (Nicholas et al, 2012; 
2014), routine outcomes were collected from three variables of interest: primary outcome 
measures; cognitive process measures; and adherence to self-management strategies. In 
addition, measures of readiness to change specific pain related behaviour and the perceived 
benefit of adhering to these behaviours were recently added to the program and were 
collected.  
 
3.2.4 (a) Primary outcome measures 
In order to address one of the limitations in current chronic pain research, a number of 
primary outcomes measures were assessed so that the unique variability of each predictor on 
the various primary outcome measures could be determined. This allows for an analysis that 
highlights the potential mechanisms of change in treatment outcomes.  
 
Roland and Morris Disability Questionnaire (RMDQ; Roland and Morris, 1983) – modified  
Pain-related disability was measured using a modified version of the RMDQ. The RMDQ 
was modified so that questions relating to back pain were simply referred to as ‘pain’. This 
measure is routinely used in the ADAPT program as participants have a range of chronic pain 
complaints. Prior investigations have demonstrated strong psychometric properties of this 
modified RMDQ measure (Asghari & Nicholas, 2001; Jensen et al., 1992). Participants 
indicate the presence of pain-related disability across 24 constructs. Scores on this measure 
range from 0 to 24, with higher scores suggestive of greater pain-related disability. In the 
current sample, the Cronbach alpha for this scale was 0.87. 
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Brief Pain Inventory (BPI; Cleeland & Ryan, 1994)  
Pain intensity and pain related interference was measured using the BPI. The BPI was 
initially developed for quantifying pain related to cancer (Cleeland and Ryan, 1994) but has 
shown good psychometric properties in chronic non-malignant pain populations (Keller, 
Bann, Dodd, Schein, Mendoza, & Cleeland, 2004; Tan, Jensen, Thornby & Shanti, 2004). 
The BPI contains two subscales: Pain intensity and pain interference. The pain intensity 
subscale of the BPI assesses pain at its “worst”, “least”, on “average” and “now”. Scores on 
the pain intensity subscale range from 0-10, with higher scores indicating greater pain 
intensity. The pain interference subscale assesses the extent that pain has interfered with 
seven activites: general activity, walking, work, mood, enjoyment of life, relations with 
others and sleep. Scores on the pain interference subscale range from 0-10, with higher scores 
indicating greater pain-related interference with everyday activities. In the current sample, the 
Cronbach alpha for the pain interference scale and the pain severity scale was 0.85 and 0.85 
respectively. 
 
Depression Anxiety Stress Scale (DASS-21; Lovibond & Lovibond, 1995) 
Depression was measured using the depression subscale of the DASS-21. The DASS has 
been shown to be a valid measure of depression in individuals with chronic pain (Taylor et 
al., 2005) with reliable specificity in distinguishing clinical from non-clinical samples 
(Antony et al., 1998). Scores on the depression subscale range from 0 to 42, with higher 
scores suggestive of more severe depressive symptoms. In the current sample, the Cronbach 
alpha for the depression scale, anxiety scale and stress scale was 0.92, 0.85 and 0.89 
respectively. 
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3.2.4 (b) Cognitive process measures 
The Pain Self-Efficacy Questionnaire (PSEQ; Nicholas, 2007)  
Self-efficacy was measured using the PSEQ. The PSEQ has good psychometric properties 
among chronic pain populations (Nicholas, 2007) and provides a measure of the individual’s 
beliefs about their ability to accomplish various activities despite their pain. Scores on the 
PSEQ range from 0 to 60, with higher scores suggestive of greater self-efficacy beliefs. In the 
current sample, the Cronbach alpha for this scale was 0.91. 
 
The Pain Catastrophising Scale (PCS; Sullivan, Bishop & Pivik, 1995)  
Catastrophic beliefs about pain were measured using the PCS. The PCS has good 
psychometric properties (Sullivan, Bishop & Pivik, 1995) and is a valid and reliable measure 
in chronic pain samples (Van Damme, Crombez, Bijttebier, Goubert & Van Houdenhove, 
2002). Scores on the PCS range from 0 to 52, with higher scores indicating higher levels of 
catastrophising. In the current sample, the Cronbach alpha for this scale was 0.93. 
 
The Tampa Scale for Kinesiophobia (TSK; Kori et al., 1990)  
Fear and avoidance beliefs associated with movement and re-injury was measured using the 
TSK. The TSK has established validity and reliability for chronic pain populations (Vlaeyen 
et al., 2002). Scores on the TSK range from 17 to 68, with higher scores suggestive of 
stronger fear and avoidance beliefs about movement and re-injury. In the current sample, the 
Cronbach alpha for the TSK was 0.87. 
 
The Injustice Experience Quenstionnaire (IEQ, Sullivan, Adams, Horan, Maher, Boland & 
Gross, 2008) 
Perceived injustice associated with injury was measured with the IEQ. The IEQ was included 
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as part of the routine battery given to patients. We report the measures here. The 
psychometric properties of the IEQ are well established in chronic pain populations (Sullivan 
et al., 2008). Scores on the IEQ range from 0 to 48, with higher scores indicating greater 
perceived injustice associated with injury. In the current sample, the Cronbach alpha for this 
scale was 0.91. 
 
3.2.4 (c) Adherence to self-management strategies 
Adherence to activity pacing, stretch exercises, goal setting, thought challenging and 
desensitisation tasks were rated at the end of each week by the treating clinical psychologist 
that was facilitating the ADAPT program. This involved rating each participants adherence to 
each self-management strategy using a scale of 0 to 2, where 0 = ’not using the strategy at 
all’, 1 = ’using it inconsistently’, and 2 = ’using it consistently’. As outline in prior research, 
using ‘inconsistently’ meant the strategy was used irregularly or less than recommended. 
Using ‘consistently’ meant the patient was using the strategy regularly each day and as 
recommended (Nicholas et al., 2012; 2014). Finally, the number of strategies consistently 
adhered to each week were determined so that each participant had a rating from 0 to 5 for 
each week.  The procedure for obtaining adherence to self-management strategies in the 
current study was more thorough than the procedure used in prior research in the same setting 
(Nicholas et al., 2012; 2014). In the current study, adherence was rated for each self-
management strategy weekly as opposed to an overall measure of adherence at the end of the 
three-week program. This procedure was adopted in an attempt to gain more information 
about adherence to each of the self-management strategies. The other way the procedure for 
obtaining adherence differed was that in the current study, the clinicians rated individuals 
adherence each week, whereas in the research conducted by Nicholas and colleagues (2012; 
2014), independent researchers provided overall adherence scores. Since therapists were 
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required to provide more information about participant adherence than previously, it was not 
possible to use the procedure whereby an independent researcher could rate adherence scores.  
 
3.2.4 (d) Perceived benefit of adherence 
The perceived benefit of adhering to each self-management strategy was rated by each 
participant at the end of each week of the ADAPT program. Participants rated the perceived 
benefit they received from using each self-management strategy using a scale of 0 to 2, where 
0 = ‘I did not benefit from using the strategy’, 1 = ‘I am unsure that I benefited from using 
the strategy’, and 2 = ‘I benefited from using the strategy’.  
 
3.2.4 (e) Readiness to change pain related behaviour 
Multidimensional Pain Readiness to Change Questionnaire 2 (MPRCQ2; Nielson, Jensen, 
Ehde, Kerns & Molton, 2008)  – modified  
Readiness to adopt pain self-management strategies promoted in the ADAPT program was 
measured using the validated MPRCQ2. In order to ensure the subscales of the MPRCQ2 
mapped to the specific self-management strategies in the ADAPT program, one subscale was 
added, as the MPRCQ2 does not have a subscale that assesses desensitisation/ interceptive 
exposure. In other words, the MPRCQ2 was modified so that participants readiness to adopt 
pain self-management strategies mapped to the specific strategies promoted in the ADAPT 
program. Specifically, activity pacing, stretch exercises, goal setting and thought challenging 
was measured using the validated pacing, exercise, task persistence and cognitive control 
subscales of the MPRCQ2 respectively. Questions were created to assess readiness to adopt 
desensitisation behaviours. Validation of the modified version of this measure is outlined in 
the results. Scores on each subscale of the MPRCQ2 range from 1 to 7, with higher scores 
indicating greater readiness to adopt the specific self-management strategy. 
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3.2.5 Sample Size 
Using GPower software it was estimated that 91 participants are required for this study.  This 
estimate is based on using F tests, an effect size of 0.2, power of 0.8 and ten covariates.  The 
effect size was based on at least a small effects size according to Cohen’s d.  
 
3.2.6 Analyses 
3.2.6 (a) Effect of the intervention on primary and cognitive process measures 
Prior to examining the effect of adherence on primary and cognitive process measures, the 
effect of the intervention on these outcomes was first determined to ensure that significant 
outcomes were achieved. A series of paired sample t-tests were conducted to compare 
changes in outcome measures from baseline to post treatment and baseline to one-month 
follow up. In addition, the mean and standard deviation of difference scores for each outcome 
was assessed between baseline to post intervention and baseline to one-month follow up so 
that that effect sizes could be determined. Effect sizes were calculated by dividing the mean 
difference score by the pooled standard deviation. Effect sizes were interpreted according to 
Cohen’s d where 0.2 is considered a small effects size, 0.5 is considered a medium effect size 
and 0.8 is considered a large effect size. 
 
3.2.6 (b) Effect of adherence on primary and cognitive process measures 
A number of analyses were conducted to determine the effect of adherence on primary and 
cognitive process measures. First, a series of univariate correlational analyses were conducted 
to ascertain if the number of strategies consistently adhered to each week was associated with 
improvements in primary and cognitive process measures. Second, a series of independent 
sample t-tests were conducted using clinically significant change estimates as a grouping 
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variable to determine whether the number of strategies consistently adhered to predicted 
clinically significant improvements in outcomes from baseline to post treatment. Estimates of 
clinically significant change were determined by calculating reliable change estimate cut-off 
points using Jacobson’s clinical significance analysis (Jacobson & Revenstorf, 1988; 
Jacobson, Roberts, Berns & McGlinchey, 1999). This analysis has been described in detail 
previously and has been used to determine clinically significant change for the same group of 
outcome variables in the same pain management program (Nicholas et al., 2012). Third, once 
the relationship between the number of strategies consistency adhered to and clinically 
significant improvements in outcomes from baseline to post treatment were established a 
series of partial correlations were conducted to determine whether these relationships held 
once controlling for the outcomes variables baseline scores. These analyses determined the 
variables that would be included in multiple regression analyses so that the unique variability 
associated with adherence and the primary outcome measures could be determined. Finally, 
multiple regression analyses were constructed in order to determine whether adherence was a 
significant independent predictor of primary outcome measures while accounting for the 
primary outcome measures baseline scores and those variables associated with the primary 
outcome measures post treatment. 
 
3.2.6 (c) Validation of the desensitisation subscale of the modified MPRCQ2 
The MPRCQ2 was modified in the current study by adding a desensitisation subscale 
consisting of four questions. In order to determine whether the desensitisation subscale can 
be used as a valid and reliable measure of desensitisation within the MPRCQ2, a number of 
analyses were conducted. A series of univariate correlational analyses were conducted to 
determine whether the desensitisation subscale was associated the other subscales of the 
MPRCQ2. Chronbach’s alpha was also calculated to determine the internal consistency 
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between the items of the desensitisation subscale and the items of the other MPRCQ2 
subscales and all items on the MPRCQ2.  
 
3.2.6 (d) Relationship between motivation and adherence 
A series of univariate correlational analyses were conducted to determine the association 
between motivation to adopt specific pain self-management strategies and adherence to these 
strategies in each week. Another series of univariate correlational analyses were conducted to 
determine whether overall readiness to adopt self-management strategies was associated with 
adherence to specific self-management strategies in each week. Overall readiness scores were 
determined by calculating the mean of all readiness items. Finally, a series of correlational 
analyses were run to determine whether overall readiness was associated with the overall 
number of self-management strategies consistently adhered to in each week. 
 
3.2.6 (e) Relationship between Benefit and adherence 
A series of univariate correlational analysis were conducted to determine the association 
between perceived benefit and the number of self-management strategies consistently 
adhered to in each week. Next, a series of multiple regression analyses were constructed to 
determine whether benefit predicted the number of strategies consistency adhered to and vice 
versa across the three weeks.  
 
3.2.7 (f) Mediation analysis 
In order to assess whether adherence mediates the relationship between readiness to adopt 
self-management strategies and primary outcome measures, while controlling for key patient 
characteristics (such as cognitive process measures), the mediation techniques outlined by 
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Baron and Kenny (1986) will be employed. An example of this mediational model is 
provided in Figure 5 below. 
 
 
Fig.5. Mediation model showing that controlling for relevant patient characteristics, such as self-
efficacy, adherence mediates the relationship between readiness to adopt certain pain self-
management behaviours and disability (pain functioning). The beta is given for each relationship. 
P<0.001.  
 
3.3. Results 
3.3.1.Demographic information 
Of the 132 people that were invited to participate in the study, 90% (n = 119) consented and 
provided baseline data. Among those that consented to participate in the study, 92% (n = 109) 
completed the three-week program and provided post intervention data, while 77% (n = 92) 
provided one-month follow-up data. No participants withdrew their consent at any point 
throughout the study.  
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The mean age of the sample was 44.7 years (SD: 12.1; range 18-74 years). Only 22% of 
participants were employed in full time paid employment. Over half of the participants were 
either unemployed due to pain (39%) or on leave from work due to pain (13%). A further 
16% of participants were working limited hours due to pain. The large majority of 
participants reported that their pain affected the number of hours they are able to work or 
study (93%) and the work they are able to do (90%). Most participants described their pain as 
always being present but of varying levels of intensity (82%). Most of the remaining 
participants reported that their pain was always present and always of the same intensity (8%) 
or often present with pain free periods of less than six hours (9%).  
 
Participants showed heavy utilisation of the health care system. Participants reported that 
they had visited their general practitioner an average of 3.36 times (SD: 2.44; range: 0-12) in 
regard to their pain in the past three months with 27.7% of the sample reporting five or more 
visits. Participants reported that they had visited health professionals other than doctors (such 
as physiotherapists and psychologists) an average of 7.90 (SD: 6.32; range: 0-40) times in 
regard to their pain in the past three months. In addition, 48.7% of the sample had visited a 
medical specialist (such as an orthopaedic surgeon) at least once, while 31.9% had at least 
one diagnostic test (such as X-rays) in the last three months in regard to their pain. Most 
(90.8%) of the participants were taking one or more medications to alleviate pain.  
 
3.3.2. Effect of the intervention on primary and cognitive process measures 
The first hypothesis that the ADAPT program would lead to improvements in pain and 
cognitive process outcomes was supported. The means and standard deviations of primary 
and cognitive process measures at baseline, post intervention and one-month follow up are 
presented in Table 4. Changes in primary and cognitive process measures from baseline to 
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post treatment and baseline to one one-month follow up are presented in Table 5 and 6 
respectively. Significant improvements were observed across all primary and cognitive 
process measures from baseline to post intervention. The average effect size for the eight 
variables during this period was 0.95, ranging from 0.22 to 1.60. The effect size for all 
primary and cognitive process variables post intervention was large, with the exception of 
pain severity, for which the effect size was small. Similarly, significant improvements were 
observed across all primary and cognitive process measures from baseline to one-month 
follow up with the exception of fear avoidance beliefs. The average effect size for the eight 
variables during this period was 0.70, ranging from 0.18 to 1.16. The effect size for all 
primary and cognitive process variables at one-month follow up was moderate to large, with 
the exception of fear avoidance and pain intensity, which were small and small to moderate 
effect sizes respectively.  
 
Table 4 
Means and standard deviations of primary and cognitive process measures at baseline, post 
intervention and one-month follow up 
 Baseline (n=119) 
Mean  
(SD) 
Post* (n=109) 
Mean  
(SD) 
1-Month* (n=92) 
Mean  
(SD) 
Disability 12.09 (5.58) 7.51 (5.66) 8.51 (6.64) 
Depression 1.26 (0.79) 0.69 (0.67) 0.81 (0.83) 
Anxiety 0.82 (0.69) 0.56 (0.57) 0.61 (0.75) 
Stress 1.48 (0.77) 1.02 (0.70) 1.05 (0.87) 
Pain Interference 5.97 (1.87) 4.19 (2.08) 4.35 (2.38) 
Pain Severity 5.69 (1.65) 5.35 (1.80) 5.15 (2.06) 
Self-Efficacy 25.16 (11.36) 41.47 (12.75) 38.15 (14.35) 
Catastrophising 23.49 (12.50) 11.73 (10.91) 12.83 (12.05) 
Fear Avoidance 37.30 (9.50) 29.20 (8.91) 35.52 (7.28) 
Injustice Experience 27.26 (11.46) 18.94 (12.35) 18.95 (13.84) 
* All mean changes from baseline to post intervention are statistically significant (see table 
5). All mean changes from baseline to follow up are statistically significant except for Fear 
Avoidance beliefs (see table 6).  
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Table 5 
Changes in primary and cognitive process measures from baseline to post intervention 
(N=119) 
 Mean 
Difference* 
Standard 
Deviation 
t p Effect Size 
Disability 4.53 4.62 10.19 <.0001 0.98 
Depression 0.56 0.65 8.81 <.0001 0.85 
Anxiety 0.24 0.50 5.06 <.0001 0.48 
Stress 0.44 0.63 7.38 <.0001 0.70 
Pain Interference 1.76 1.86 9.62 <.0001 0.94 
Pain Severity 0.36 1.60 2.33 .022 0.22 
Self-Efficacy 16.39 10.22 16.59 <.0001 1.60 
Catastrophising 11.68 10.86 11.12 <.0001 1.08 
Fear Avoidance 7.68 7.21 10.7 <.0001 1.06 
Injustice Experience 8.01 9.07 9.05 <.0001 0.88 
* All difference scores have been attributed a positive value and represent improvements in 
the outcome measures from baseline to post intervention.  
 
 
Table 6 
Changes in primary and cognitive process measures from baseline to one-month follow up 
(N=119) 
 Mean 
Difference* 
Standard 
Deviation 
t p Effect Size 
Disability 3.35 6.00 5.18 <.0001 0.56 
Depression 0.43 0.68 5.61 <.0001 0.63 
Anxiety 0.22 0.65 3.00 0.004 0.34 
Stress 0.42 0.66 5.91 <.0001 0.64 
Pain Interference 1.65 1.91 7.95 <.0001 0.86 
Pain Severity 0.54 1.74 2.87 0.005 0.31 
Self-Efficacy 12.65 10.93 10.67 <.0001 1.16 
Catastrophising 11.02 10.69 9.40 <.0001 1.03 
Fear Avoidance 1.35 7.31 1.62 0.109 0.18 
Injustice Experience 8.08 9.75 7.40 <.0001 0.83 
* All difference scores have been attributed a positive value and represent improvements in 
the outcome measures from baseline to one-month follow up.  
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3.3.3. Effect of adherence on primary and cognitive process measures post intervention 
The second hypothesis that adherence to the self-management strategies promoted in the 
ADAPT program would predict improvements in pain and cognitive process measures was 
not supported. A series of univariate correlational analyses revealed that adherence was 
associated with improvements in disability and pain self-efficacy at the conclusion of the 
intervention but no other primary or cognitive process outcomes. Specifically, improvements 
in disability at post intervention were associated with the number of strategies consistently 
adhered to in week two (r = .192, p = .047) and week three (r = .224, p = .023). 
Improvements in self efficacy post intervention were associated with the number of strategies 
consistently adhered to in week one (r = .234, p = .016), week two (r = .349, p <.0001) and 
week three (r = .279, p = .005). For a full list of correlations see appendix D.  
 
To determine whether the number of strategies consistently adhered to predicted clinically 
significant improvements in disability from baseline to post treatment a series of independent 
sample t-tests were conducted using clinically significant change as a grouping variable. The 
number of strategies consistently adhered to was not associated with clinically significant 
improvements in disability from baseline to post treatment in week one (F = 2.89, p = .092), 
week two (F = .00, p = .986) or week three (F = 3.749, p = .056).  
 
Since the second hypothesis that adherence would predict the primary outcome (disability) 
was not supported, a number of exploratory and hypothesis generating analyses were 
conducted.  First, a series of partial correlations were conducted to determine the baseline 
measures that were associated with post treatment disability, while controlling for pre 
treatment disability scores. The following variables were associated with post disability 
scores while taking into account baseline disability: self-efficacy (r = .447, p <.0001); fear 
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avoidance (r = .374, p = .002); injustice (r = .300, p = .014); adherence in week 2 (r = .330, 
p = .007) and week 3 (r = .366, p = .003); and perceived benefit in week 1 (r = .361, p = 
.003) and week 2 (r = .247, p = .036). Next, a multiple regression analysis was constructed in 
order to determine whether adherence was a significant independent predictor of disability 
post treatment. On the first step of the model, pre treatment disability was added and was 
strongly associated with disability at post treatment (F = 23.48, p < 0.0001), accounting for 
27% of the variance. Adding those variables that were associated with disability post 
treatment, while controlling for baseline disability (self-efficacy, fear avoidance and injustice 
beliefs) added significant variance to the model (F = 4.727, p = 0.005). However, only 
baseline disability was a significant predictor (t = 2.34, p = 0.023) and together, self-efficacy, 
fear avoidance, and injustice beliefs accounted for only 14% of the variance in disability. On 
the third step, adherence in weeks 2 and 3 and perceived benefit in weeks 1 and 2 was added 
but was not significantly associated disability post treatment (F = 0.628, p = 0.645). 
However, once these variables were added, there were no significant predictors of disability 
and together, adherence in weeks 2 and 3 and perceived benefit in weeks 1 and 2 only 
accounted for 2.5% of the variance in disability.  
 
3.3.4. Effect of adherence on primary and cognitive process measures one-month post 
intervention 
A series of univariate correlational analyses revealed that adherence was associated with 
improvements in pain self-efficacy, catastrophising and injustice beliefs at one-month follow-
up but no other primary or cognitive process outcomes. Specifically, improvements in pain 
self-efficacy at one-month follow-up were associated with the number of strategies 
consistently adhered to in week one (r = .231, p = .033), week two (r = .249, p = .022) and 
week three (r = .247, p = .027). Improvements in pain catastrophising at one-month follow-
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up were associated with the number of strategies consistently adhered to in week two (r = 
.235, p = .034). Similarly, improvements in injustice beliefs at one-month follow-up were 
associated with the number of strategies consistently adhered to in week 2 (r = .226, p = 
.046). 
 
3.3.5 Validation of the desensitisation subscale of the modified MPRCQ2 
Prior to assessing the relationship between readiness scores and adherence, the internal 
reliability and validly of the desensitisation subscale of the modified version of the MPRCQ2 
was examined. A series of univariate correlational analyses revealed that the desensitisation 
subscale showed significant moderate to large correlations with thought challenging (r = 
.708, p = <.0001), goal setting ((r = .652, p = <.0001) and pacing (r = .588, p = <.0001), and 
a significant small to moderate correlation with stretching/exercise (r = .360, p = <.0001). 
Next, Chronbach’s alpha was calculated to measure the internal consistency between the 
items of the desensitization subscale and those items of the other subscales. The internal 
consistency between all readiness items was excellent (α= .937). The desensitization 
subscale showed good internal consistency with thought challenging (α= .898), goal setting 
(α= .791), pacing (α= .862) and stretching/exercise (α= ..847). However, the internal 
consistency of items within the desensitization subscale was not acceptable (α= 579). Thus, 
while there is good evidence of content validity as the desensitisation subscale contributed in 
a way that maintained consistency with the total measure, there are an insufficient number of 
items in the desensitization subscale to use as a valid and reliable stand-alone measure.  
 
3.3.6. Relationship between motivation and adherence  
The third hypothesis that readiness to adopt the pain self-management strategies promoted in 
the ADAPT program would predict adherence to these strategies was not supported. A series 
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of correlational analyses showed that readiness for each pain self-management strategy was 
not associated with adherence to those strategies, with the exception of readiness for 
stretching, which was associated with adherence to stretching in week one (r = .258, p = 
.006) but not in weeks two or three. Next, a series of univariate correlational analyses were 
conducted to determine whether overall readiness to adopt self-management strategies was 
associated with adherence to these specific self-management strategies. Overall readiness was 
calculated by determining the mean of all readiness items. Overall readiness was not 
associated with adherence to any self-management strategies, with the exception of 
adherence to pacing in week two (r = .206, p = .040) but not weeks one or three. Finally, a 
series of correlational analyses were run to determine whether overall readiness was 
associated with the number of self-management strategies consistently adhered to in each 
week. Overall readiness was not associated with the number of self-management strategies 
consistently adhered to in any week. Since readiness to adopt pain self-management 
strategies did not predict adherence to these strategies, the fourth and fifth hypotheses could 
not be explored. That is, it was not possible to assess whether: readiness to adopt pain self-
management strategies predicts adherence to these strategies over and above other relevant 
variables, such as self-efficacy (hypothesis 4); and adherence to pain self-management 
strategies mediate the relationship between individuals’ readiness to adopt pain self-
management strategies and pain outcomes (hypothesis 5).  
 
3.3.7 Relationship between benefit and adherence 
The sixth hypothesis that individual’s beliefs about the perceived benefit in using self-
management strategies would predict adherence to these strategies was supported. However, 
the seventh hypothesis that adherence to pain self-management strategies would predict 
individual’s perceived benefit in using these strategies was not supported. While the number 
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of self-management strategies consistently adhered to each week increased throughout the 
program, the perceived benefit of using self-management strategies only increased between 
week one and two and was unchanged in week three. The means and standard deviations of 
the clinician ratings of adherence to each self-management strategy at the end of each week 
are displayed in table 7. The means and standard deviations of the number of self-
management strategies consistently adhered to and the perceived benefit of using these 
strategies each week are displayed in Table 8. 
 
Table 7. 
Means and standard deviations of the clinician ratings of adherence to each self-
management strategy at the end of each week 
 Week 1 
(SD) 
Week 2 
(SD) 
Week 3 
(SD) 
Activity Pacing 1.37 (0.58) 1.41 (0.66) 1.53 (0.59) 
Goal Setting 1.48 (0.54) 1.45 (0.64) 1.63 (0.54) 
Thought Challenging 1.10 (0.55) 1.15 (0.64) 1.32 (0.64) 
Desensitisation 1.46 (0.60) 1.50 (0.64) 1.53 (0.63) 
Stretch exercises 1.90 (0.31) 1.82 (0.41) 1.80 (0.43) 
*Clinician rating of participants use of self-management strategy used the scale of 0 to 2, 
where 0 = ’not using the strategy at all’, 1 = ’using it inconsistently’, and 2 = ’using it 
consistently’.  
 
Table 8. 
Means and standard deviations of the number of self-management strategies consistently 
adhered to and the perceived benefit of using these strategies each week 
 Week 1 
(SD) 
Week 2 
(SD) 
Week 3 
(SD) 
Adherence  2.53 (1.58) 2.73 (1.76) 3.06 (1.78) 
Perceived Benefit 1.65 (0.33) 1.80 (0.27) 1.80 (0.28) 
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The correlations between the number of strategies consistently adhered to and the perceived 
benefit at each week are shown in Table 8. Adherence each week was associated with benefit 
each week.  
 
Table 9. 
Correlation between the number of self-management strategies consistently adhered to and 
the perceived benefit each week 
 
 
 
 
 
 
 
 
 
 
 
 
A regression analysis was constructed in order to determine whether benefit in week 1 
predicted adherence in week 1. Benefit in week one was a significant independent predictor 
of adherence in week 1 (F = 5.97, p = .016), but accounted for only 6% of the variance. 
 
A multiple regression analysis was constructed in order to determine whether benefit 
predicted adherence in week 2. On the first step of the model, adherence in week 1 was added 
and was strongly associated with adherence in week 2 (F = 43.30, p < 0.0001), accounting for 
30% of the variance. Adding perceived benefit on week 1 added significant variance to the 
model (F = 5.701, p = 0.019). Benefit in week 1 was a significant independent predictor (t – 
2.388, p = 0.019) and with adherence in week 1, benefit in week 1 only accounted for 4% of 
the variance in adherence in week2. 
 
  r (p value)  
 Benefit  
Week 1 
Benefit  
Week 2 
Benefit  
Week 3 
Adherence 
Week 1 
.237 (.016) .273 (.006) .242 (.014) 
Adherence 
Week 2 
.320 (.001) .345 (<.0001) .231 (.019) 
Adherence 
Week 3 
.382 (<.0001) .478 (<.0001) .319 (.001) 
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A multiple regression analysis was constructed in order to determine whether benefit 
predicted adherence in week 3. On the first step of the model, adherence in weeks 1 and 2 
were added and was strongly associated with adherence in week 3 (F = 61.89, p < 0.0001), 
accounting for nearly 60% of the variance. Despite the high level of variance accounted for, 
adding perceived benefit in weeks 1 and 2 still added significant variance to the model (F = 
37.164, p < 0.0001). However, it is notable that only benefit in week 2 was a significant 
independent predictor (t – 2.519, p = 0.014) and together previous perceived benefit only 
accounted for 5% of the variance in adherence. 
 
A regression analysis was constructed in order to determine whether adherence in week 1 
predicted benefit in week 1. Adherence in week 1 was a significant independent predictor of 
benefit in week 1 (F = 5.97, p = .016), but accounted for only 6% of the variance. 
 
A multiple regression analysis was constructed in order to determine whether adherence 
predicted benefit in week 2. On the first step of the model, benefit in week 1 was added and 
was strongly associated with benefit in week 2 (F = 57.06, p < 0.0001), accounting for 39% 
of the variance. Adding adherence in week 1 failed to add significant variance to the model 
(F = 3.614, p = 0.061). Therefore, the change in benefit in week 2 was better accounted for 
by benefit in week 1 than adherence in week 1.  
 
A multiple regression analysis was constructed in order to determine whether adherence 
predicted benefit in week 3. On the first step of the model, benefit in weeks 1 and 2 were 
added and was strongly associated with benefit in week 3 (F = 30.84, p < 0.0001), accounting 
for nearly 43% of the variance. Despite the high level of variance accounted for, adding 
adherence on weeks 1 and 2 still added significant variance to the model (F = 15.68, p < 
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0.0001). However, neither adherence in week 1 or two were independent predictors of benefit 
in week 3 and together previous adherence only accounted for 1% of the variance in benefit. 
 
3.4. Discussion 
3.4.1. Summary of study results 
Results from the current study confirmed the well-established efficacy of the ADAPT 
program, consistent with the study’s first hypothesis. However, contrary to the study’s second 
hypothesis, the study failed to replicate the finding that adherence to pain self-management 
strategies predicted improvements in pain outcomes. Further, investigations into individual’s 
motivation to adopt pain self-management strategies failed to find any association between 
readiness and adherence to these strategies, which is inconsistent with the studies third, fourth 
and fifth hypothesis. The major finding from this study, consistent with the study’s sixth 
hypothesis, was that participant’s perceived benefit of using self-management strategies was 
an independent predictor of adherence to these strategies during subsequent weeks of the pain 
management program, particularly early in treatment. In contrast, while adherence during the 
first week predicted perceived benefit of using the self-management strategies in the same 
week, adherence did not predict individual’s perceived benefit during any subsequent weeks, 
inconsistent with the study’s seventh hypothesis.  
 
3.4.2. Interpretation of findings and significance of results  
3.4.2.a) Effect of adherence on primary and cognitive process outcomes 
Adherence was not a predictor of improvements in primary pain outcomes post intervention 
or at one-month follow up when accounting for baseline scores and key cognitive process 
measures in the current study. These results are inconsistent with the reported robust findings 
of past research that found adherence to be an independent predictor of improvements in pain 
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severity, disability and depression, even when controlling for key cognitive process measures 
(Nicholas et al., 2012; 2014). The most likely explanation for the different results stem from 
the variation in the way adherence was measured. As outlined earlier, in the two studies 
carried out by Nicholas and colleagues (2012; 2014), an overall measure of adherence was 
provided by an independent researcher at the end of the three week program after inspecting 
the treating clinical psychologists brief notes about the individual’s participation and their 
worksheets. In contrast, the current study measured adherence to each specific self-
management strategy weekly and scores were based on the treating clinical psychologists’ 
rating alone, as the patients’ worksheets were not available. The method for obtaining 
adherence in the current study was more thorough than the prior studies conducted by 
Nicholas and colleagues (2012:2014) in two specific ways. Firstly, adherence was rated on 
each specific self-management strategy, whereas there was an overall rating given in the prior 
studies. Secondly, adherence was rated weekly during the three weeks of treatment, as 
opposed to at the conclusion of the program. As a result more information was obtained on 
adherence in the current study. However, it is possible that the measure of adherence in the 
current study was less valid as it was not cross-validated by an independent researcher and 
thus allows for therapist bias. For example, since the treating clinician was aware that their 
rating would not be cross validated by an independent researcher, the clinician may have had 
a tendency to overestimate the participants level of adherence to reflect positively regarding 
the outcomes of their group or they may not have paid as much attention to the participant 
worksheets when making their decision about the participants level of adherence. While these 
are legitimate concerns, the distribution of adherence rates in the current study is almost 
identical to those reported in the other two studies (Nicholas et al., 2012; 2014), and the staff 
are also largely the same people who made the ratings previously. For example, in the study 
by Nicholas and colleagues (2012), participants consistently adhered to the following number 
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of strategies: five (31.2%); four (19.4%); three (14.5%); two (13.8%); one (11.8%); and none 
(9.3%). In the current study, participants consistently adhered to the following number of 
strategies: five (32.1%); four (16%); three (14.2%); two (11.3%); one (16.0%); and none 
(10.4%). Therefore, it is unlikely that overestimates of adherence can fully account for the 
differing findings.  
 
Another possible reason for the null finding regarding adherence and key outcomes in the 
current study may be due to differences in the way adherence was analysed compared with 
past studies. In the two studies carried out by Nicholas and colleagues (2012; 2014), the 
authors simplified the analysis by combining the six adherence groups into three clusters. The 
first cluster consisted of individuals that consistently adhered to four or five strategies, the 
second cluster consisted of individuals that consistently adhered to two or three strategies, 
and the third cluster consisted of those who consistently adhered to one or no strategies. 
Analyses then compared the relationship between the three clusters and outcome variables. In 
contrast, the current study did not simplify the analysis but compared the six adherence 
groups and key outcome variables. The advantage of this approach is that the study findings 
are more sensitive to determining the extent to which the different levels of adherence impact 
on key outcomes. However, by simplifying the analysis you also increase the likelihood of 
finding a significant relationship between adherence and key outcome variables as you are 
looking at fewer variables and consequently have increased power to detect an effect. In 
order to rule out this potential confounder, an analysis was conducted using the same 
procedure that was used in past studies (Nicholas et al., 2012; 2014), and the results were 
unchanged (see Appendix D for output of analysis). It is therefore also unlikely that this can 
fully account for the contradictory findings. It is worth noting that Nicholas and colleagues 
(2014) did find that adherence was a better predictor of long-term outcomes compared to 
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short term outcomes and it raises the possibility that the study may have been more likely to 
find an effect should the follow up period have been longer, though this is purely speculative.  
 
It is important that the results of the current study are viewed with caution as the findings are 
inconsistent with prior research in the same setting that replicated their results with larger 
samples (Nicholas et al., 2012: 2014). However, the findings from the current study raise 
some questions about the importance of adherence in chronic pain treatment. The results 
show that there was no additional advantage in adhering to the self-management strategies 
that were taught in the pain management program in the cohort of participants. Interestingly, 
the results of the current study are similar to those found by Curran, Williams and Potts 
(2009), who used structural equation modeling techniques in a longitudinal dataset to assess 
whether adherence to cognitive behavioural treatments predicted pain outcomes. The authors 
assessed whether self-reported adherence to exercise, stretching, pacing, and cognitive 
techniques at one month post treatment predicted improvements in depression, self-efficacy 
and catastrophising, which were measured at baseline, post treatment and at one-month 
follow up.  They reported that although adherence partially mediated depression, self-efficacy 
and catastrophising between post treatment and one-month follow up, it only accounted for 
3% of the variance in these outcomes at follow up. The majority of the variance (69%), in 
contrast, was explained simply by post treatment scores. That is, those patients whose scores 
were low at post-treatment, were also most likely to have low scores at follow-up. It is 
important to note however, that the measurement of adherence in this study was simply self-
reported by participants of the cognitive behavioural treatments. Hence, this study relied on a 
significantly less robust definition of adherence than in the Nicholas (2012, 2014) studies. 
Further, adherence was only measured at one month follow up and not during treatment or at 
the end of treatment. Regardless, the study findings are similar to that of the current study 
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and indicate that perhaps the weight attributed to adherence in current treatment is not 
warranted. At the very least, they highlight the need for more research into the reliability and 
validity of adherence measures so that research can clarify these conflicting findings.  
 
3.4.2.b) Relationship between motivation and adherence 
Although there has been no prior research exploring the relationship between readiness to 
change and adherence in chronic pain, the finding that readiness to change at baseline was 
not associated with adherence to self-management strategies throughout the pain 
management program was unexpected, as it is inconsistent with the motivational model of 
pain self-management (Jensen, Nielson & Kerns, 2003). One explanation for this finding is 
that the measurement of readiness at baseline was not sensitive enough to capture the 
dynamic change process. Prior research has shown that readiness at baseline predicts 
completion of pain management programs (Biller et al., 2000; Gersh, Arnold & Gibson, 
2011; Kerns & Rosenberg, 2000), but not necessarily pain outcomes. Rather, increases in 
readiness to adopt pain self-management strategies throughout the program predict pain 
outcomes (Burns et al., 2005; Gersh, Arnold & Gibson, 2011; Glenn & Burns, 2003; Kerns & 
Rosenberg, 2000). It is possible that readiness changes rapidly throughout the program. As a 
result, in order to adequately test the hypothesis that adherence is the mechanism through 
which readiness results in improved pain outcomes, one would need to assess readiness and 
adherence throughout the program in order to observe these rapid changes. Unfortunately, in 
order to ensure a thorough measurement of readiness to change, the motivational measure 
used in the current study was very long because it assessed readiness to each specific self-
management strategy in the ADAPT program. As a result, it was not feasible to administer on 
multiple occasions, particularly in the context of a clinical setting where measures were not 
traditionally designed for research purposes but as ongoing evaluation of the program. Since 
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the current study only measured readiness at baseline, it would not have been sensitive to the 
changes in readiness throughout the program, which consequently may have resulted in these 
null findings. In other words, while the current study did not find a relationship between 
readiness at baseline and adherence, it is possible that a relationship would have been found 
if the measure of readiness had been re-administered in order to capture change throughout 
the program. Indeed, in the drug and alcohol field it is not uncommon for individual’s levels 
of readiness to fluctuate and the change process is not considered linear (Copeland, Frewen & 
Elkins, 2009; Marshg, Dale & Willis, 2007). Regardless, given the fact that adherence was 
measured at the end of the first week, it was reasonable to expect the baseline level of 
motivation to predict early adherence, though it did not. This study has highlighted a 
potential problem for the TTM and motivational model of pain self-management since 
readiness did not predict adherence at the end of the first week. Future research should assess 
the relationship between readiness and adherence throughout treatment to ascertain the nature 
of this dynamic change process.  
 
Another possible explanation for the null finding regarding readiness and adherence may 
relate to the inherent motivation of individuals attending the pain management program. For 
example, participants in the current study have generally had numerous unsuccessful 
treatments, and are experiencing significant pain related disability. These factors, among 
others, may have impacted on participant’s readiness as a whole. For example, it is possible 
that this program represents a last resort to many participants, thereby increasing their 
motivation to engage in self-management strategies. On the other hand, due to the number of 
failed attempts to improve their pain, participants in this program may be extremely 
unmotivated to use self-management strategies due to feelings of helplessness. Should the 
participants of the current program not be representative of prior chronic pain populations, 
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the readiness measure may not be valid or generalisable to this population, thereby resulting 
in the null findings. However, based on the norms provided by Nielson et al. (2008), the 
readiness scores of participants in the current study are comparable to that of the other 
chronic pain populations with which the measure was initially developed and validated. This 
suggests that the measure of readiness to adopt specific pain self-management strategies 
among participants in the current study is likely to be representative of individuals attending 
chronic pain management programs and the readiness findings from this chronic pain 
population are likely to be generalisable to other chronic pain populations.  
 
3.4.2.c) Relationship between perceived benefit and adherence 
The current study highlighted the importance of individual’s perceived benefit in using self-
management strategies, as this independently predicted the number of strategies that 
individuals consistently adhered to during subsequent weeks of the program. Interestingly, 
the capacity of perceived benefit to predict adherence was strongest in the first week of the 
program and perceived benefit in week one predicted adherence in weeks one and two but not 
week three. This suggests that perceived benefit early in the program may be more important 
for increasing adherence than perceived benefit later in the program. In other words, 
improving participant’s perceived benefit of using self-management strategies early in 
treatment may have a greater impact on increasing adherence to these strategies than if done 
later in the program. According to social cognitive theory and CBT, directly observing other 
people making behaviour changes that are associated with functional improvements or 
listening to past participants who were in similar circumstances explain the consequences of 
using self-management strategies, may alter current participants beliefs about the outcomes 
of adopting new pain related behaviours and their ability to change (Bandura et al., 1986; 
Jensen et al., 2003; Turk, 2002). For example, there may be value in past participants sharing 
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their account of the benefit they received from using the self-management strategies with 
current participants in the early stages of the pain management program. Future research 
should explore the different types of interventions that increase individual’s perceived benefit 
and their impact on adherence and pain outcomes.  
 
The relationship between perceived benefit and adherence appears to be unidirectional, as 
only adherence in the first week independently predicted perceived benefit in the same week 
but not subsequent weeks. In other words, while individuals are more likely to use self-
management strategies because they perceive a benefit in doing so, using self-management 
strategies does not seem to increase the perceived benefit of these behaviours. This is 
surprising on a number of levels. First, consistent adherence in any week was a strong 
predictor of future consistent adherence. It may be that there is a group of individuals who 
initially adhere and they are more likely to adhere throughout the program irrespective of 
their perceived benefit of doing so, whereas a subgroup of individuals also adhere because 
they perceive a benefit in doing so, at least early in treatment. Second, based on CBT 
literature, one would predict that engaging in a cognitive behavioural self-management 
strategy would alter the individual’s beliefs about the consequences of the behavior and the 
true benefit of performing the behaviour (Turk, 2002). Clearly, further research is needed to 
understand the mechanisms whereby perceived benefit promotes adherence, particularly in 
cognitive behavioural pain self-management programs. . 
 
The finding that perceived benefit predicted adherence to pain self-management strategies is 
consistent with social learning theory (Bandura, 1977), social cognitive theory (Bandura, 
1986) and the health belief model (Rosenstock, 2000) and is partially consistent with the 
motivational model of pain self-management (Jensen, Nielson & Kerns (2003). According to 
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the motivational model of pain self-management, perceived benefit, along with the 
individuals ‘learning history’ and ‘current contingencies’ make up the construct ‘perceived 
importance’. Perceived importance and self-efficacy are then thought to predict adherence to 
self-management strategies, with both constructs being mediated by readiness to change. 
Interestingly, perceived benefit predicted adherence in the current study, however it did not 
appear to be mediated by readiness, at least not baseline readiness. In order to further 
understand the relationship between benefit and adherence, a more sensitive measure that 
captures the dynamic nature of readiness is needed.  Taken together, the study findings 
suggest that it would be advantageous to further validate the various components of the 
motivational model of pain self-management, such as the impact of perceived benefit on 
adherence while controlling for the other components of perceived importance. More broadly 
speaking, this study has highlighted the clear potential to improve adherence to pain self-
management programs by understanding the variables that contribute to adherence, such as 
perceived benefit.  
 
3.4.3. Study limitations 
The measurement of readiness was a limitation of the current study for a number of reasons. 
First, readiness was only measured at the start of treatment and not throughout. As 
mentioned, this may have affected the ability of the current study to capture the dynamic 
nature of readiness (Prochaska & DiClemente, 1983; Prochaska & Velicer, 1997) to adopt 
pain self-management strategies and could explain the null findings regarding the relationship 
between readiness and adherence. Nonetheless, while this limitation in the study 
methodology has theoretical implications and may have impeded on the ability to explore any 
potential relationship between readiness and adherence, it does highlight the clinical 
implications for chronic pain treatment, such as the limitations for providing stage matched 
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treatment. Second, the current study utilised a measure that was sensitive to readiness to 
specific self-management strategies as opposed to a global measure. While the advantages to 
this approach have already been discussed, such as improved specificity (Nielson et al., 
2008), this approach limited the ability to assess global readiness. Since no relationship was 
found between readiness and adherence using the self-management specific measure, overall 
scores from this measure were averaged to gain overall readiness scores. In addition to 
utilising the measure of readiness used in the current study, it would have been beneficial to 
use a standardized global measure of readiness that had been readily applied to research in 
chronic pain. For example, the PSOCQ (Kerns et al., 1997) has largely been used in chronic 
pain research and while the use of this measure may not have changed the study findings, it 
would have at least provided a more standardized measure of global readiness so that the 
study findings were more generalizable and able to be directly contrasted with the findings of 
past research. Nevertheless, it was not feasible to add further measures in the current study 
given the high burden on participants to complete a battery of measures across numerous 
time points. Future research may want to consider the use of both measures to ensure 
specificity in readiness but also a more standardized global measure of readiness.  
 
The procedure for obtaining adherence ratings may have impacted on the validity of 
adherence scores. As outlined earlier, in an attempt to gain more information and valid data 
on adherence to pain self-management strategies than past research in the same setting 
(Nicholas et al., 2012; 2014), the current study gained clinician ratings of participant’s 
adherence to each self-management strategy weekly as opposed to an overall score at the end 
of the program. However, due to this increased demand on clinicians to provide more 
information about specific self-management strategies and more frequently, it was not 
possible for clinicians to also provide information on adherence to each specific self-
management strategy so that an independent researcher could provide adherence ratings. 
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Since the robust findings of Nicholas and colleagues, that adherence predicts pain outcomes, 
could not be replicated, it may be that the extra information on adherence was obtained at the 
expense of more valid information. In other words, it may be that clinicians are better at 
getting an overall impression of adherence than rating adherence to each individual strategy. 
Irrespective of clinicians’ ability to provide valid ratings of overall adherence as opposed to 
adherence to specific strategies, the finding that computed overall adherence scores in the 
current study was at least associated with pain outcomes while adherence to each specific 
self-management strategy was not, suggests that overall adherence scores may actually be 
more useful.  
 
There are also a number of other potential limitations to the study’s measure of adherence. 
Adherence ratings were based on the clinical psychologists observation of participants 
behaviour and their clinical judgment, which may be less valid with certain self-management 
strategies that are harder to observe, such as thought challenging. It is unknown if clinicians 
perceptions of participants of adherence are as important as participants perceptions of their 
own adherence to predicting self-reported outcomes. It is possible that the use of the three 
point rating scale carries inherent limitations. Finally, assessing the number of strategies that 
participants consistently adhered to carries with it the assumption that all strategies are 
equally important to all participants.  
 
 
Another limitation of the current study was the large number of outcome measures and 
subsequent correlational analyses that were performed. For example, analysing the large 
number of correlations between readiness and adherence to the numerous self-management 
strategies in each week increases the chance of finding significant correlations, particularly as 
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adherence to the different self-management strategies are likely to share variance with one 
another. This method of analysis would have been particularly problematic if the study found 
numerous significant associations between readiness and outcome measures. However, since 
the study failed to find any evidence that readiness to adopt pain self-management strategies 
was associated with adherence, the evidence appears conclusive that motivation to change 
prior to the program is not associated with adherence throughout the program, even at the end 
of the first week. 
 
Finally, it is possible that missing data could have impacted on the study findings. For 
example, it is feasible that individuals that did not adhere did not provide post treatment or 
one-month follow-up data. Missing values were not replaced as the aim of the analysis is to 
determine the relationship between variables within a sample. Nonetheless, independent 
sample t-tests were carried out to determine whether the group means of those who dropped 
out of treatment differed to those who completed treatment and there were no significant 
differences in the number of strategies that individuals consistently adhered to at the end of 
the first week or post treatment. The analysis is provided in Appendix D.  
 
3.4.4. Study strengths 
This is the first study to assess the relationship between motivation to adopt pain self-
management strategies and adherence to these specific strategies in chronic pain. This is a 
developing and important area to investigate for theoretical and clinical reasons given the 
underwhelming effect sizes of current treatments for chronic pain (Eccleston, Morley & 
Williams, 2013) and the reported significance of adherence to chronic pain treatment 
(Nicholas et al., 2012; 2014). This is also the first study to assess the relationship between 
individual’s perceived benefits of adhering to pain self-management strategies and the use of 
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these strategies, a relationship thought to drive adherence to pain self-management strategies 
according to Jensen, Nielson and Kerns’ (2003) motivational model of pain self-management. 
Finally, the fact that this research was carried out with a clinical population in a real-life 
treatment setting represents a relative strength as the study findings are generalisable to 
current treatment programs and have the potential to influence future clinical practice.  
 
3.4.5. Conclusion 
This study assessed whether readiness to adopt pain self-management strategies and beliefs 
about the perceived benefit of using these strategies were related to adherence among 
individuals with chronic pain attending a pain management program. In addition, the role of 
adherence in mediating other cognitive processes and key pain outcomes were examined. The 
major finding from the present study was the importance of beliefs about the perceived 
benefit of adhering to pain self-management strategies. The study found that perceived 
benefit was a significant predictor of adherence, although it only accounted for a small 
amount of variance. Critically, perceived benefit was the most salient predictor of adherence 
early in treatment, suggesting that pain management programs may increase adherence rates 
through interventions that target perceived benefits of using self-management strategies, and 
including them early in treatment. Interestingly, only adherence in the first week was a 
predictor of individual’s perceived benefit of using self-management strategies in the first 
week, but not subsequent weeks, showing that using the self-management strategies does not 
seem to increase the perceived benefit of doing so. Although this was the first study to assess 
the relationship between readiness and adherence to pain self-management strategies in 
chronic pain, the findings of the present study appear inconsistent with the TTM and 
motivational model of pain self-management and suggest that readiness at the beginning of 
treatment does not predict adherence to self-management strategies. It is important that these 
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findings are viewed with caution given the limitations in the study design and further 
research is needed to replicate these results. Surprisingly, the present study also failed to 
replicate the findings of past research that found adherence to be a significant independent 
predictor of cognitive processes and key pain outcomes. These findings bring into question 
the importance of adherence to self-management strategies and indicate that perhaps 
adherence is no more important than other key mediators and moderators of pain outcomes. 
The current study also highlights the difficulties of measuring adherence and there is a clear 
need for more standardised and robust methods of determining adherence.  
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Chapter 4 
General Discussion 
4.1. Summary of main results 
The principal aim of this research project was to explore the relationship between 
individual’s readiness to adopt a variety of pain self-management behaviours, adherence to 
these strategies and key pain outcomes in order to gain a better understand of how to improve 
current chronic pain treatment and to test predictions from the TTM and the motivational 
model of pain self-management. The research project also sought to understand the 
importance of individual’s perceived benefit in performing self-management strategies to 
obtain a greater understanding of the potential mechanisms driving readiness to adopt these 
strategies. The research took two approaches. First, a meta-analysis and systematic review 
was carried out to investigate the efficacy of motivational interviewing approaches on 
adherence to chronic pain treatment and pain outcomes. Second, an empirical study was 
carried out to explore the mechanisms through which motivational interviewing may impact 
on pain outcomes by exploring the relationship between readiness to adopt pain self-
management strategies, adherence to these strategies and key pain outcomes among 
individuals with chronic pain attending a multidisciplinary pain management program. 
 
The first study aimed to determine whether motivational interviewing approaches had the 
potential to increase adherence to chronic pain treatments and the subsequent impact on pain 
outcomes. A meta-analysis and systematic review was carried out to determine the efficacy 
of motivational interviewing approaches on adherence to chronic pain treatment and 
improvements in disability and pain intensity. The final analysis was based on seven RCTs 
with 962 participants, none of which consisted of the gold standard multidisciplinary 
cognitive behavioural pain management treatment. The results showed that motivational 
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interviewing had a small to moderate effect on increased adherence to treatment and a small 
effect on improvements in pain intensity from baseline to post intervention but not six-month 
follow up. Unfortunately, there were not enough studies to assess the effect of motivational 
interviewing on disability from baseline to post intervention, though none of the three 
available studies showed gains compared with the control groups. Moreover, no effects of 
motivational interviewing on disability from baseline to six-month follow up were observed. 
Although the results of this study should only be viewed as preliminary given the small 
sample size and subsequent potential for publication bias, they clearly demonstrate the 
potential for motivational interventions to increase adherence to chronic pain treatments and 
improvements in pain outcomes, at least in the short term. However, the association with 
long-term function was not supported.    
 
The second study was designed to further understand the mechanisms through which 
adherence may mediate the relationship between readiness and pain outcomes. This study 
aimed to determine whether readiness to adopt pain self-management strategies predicted 
adherence to these strategies and if so whether adherence mediated the relationship between 
readiness and pain outcomes. It also sought to determine whether individual’s beliefs about 
the perceived benefit of performing self-management strategies predicted adherence to these 
strategies. Inconsistent with the proposed motivational model of pain self-management 
(Jensen et al., 2003), the study found that readiness to adopt pain self-management strategies 
at baseline did not predict adherence to these strategies. This study also failed to replicate the 
findings of past research carried out in the same setting (Nicholas et al., 2012: 2014) that 
showed adherence to be an independent predictor of pain outcomes. The key finding from the 
current study was that participant’s perceived benefit in adhering to pain self-management 
strategies predicted future adherence, particularly early in the program. In contrast, 
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performing self-management strategies did not predict future perceived benefit in adherence. 
The findings from this study and the meta-analysis and systematic review have implications 
for our understanding of current health psychology models and motivational models in 
chronic pain and provide important considerations for future research. These matters are 
discussed in turn. 
 
4.2. The transtheoretical model and motivational models in chronic pain 
The findings from the current research project are largely at odds with the transtheoretical 
model (TTM) and the motivational model of pain self-management (Jensen et al., 2003). One 
of the core constructs of the TTM is the temporal aspect of change or stage of change. 
Essentially the model proposes that individuals go through distinct changes before adopting 
and maintaining new behaviours whereby progression across the stages increase the 
likelihood of the individual performing that new behaviour (Prochaska & Velicer, 1997). The 
motivational model of pain self-management adopts this principle and proposes that 
individual will adhere to self-management strategies as a function of their readiness to use 
these strategies (Jensen et al., 2003). The findings from the meta-analysis and systematic 
review seem to support the assumption that readiness facilitates adherence to chronic pain 
treatment. However, none of the included studies assessed whether MI improved adherence 
by changing the individual’s readiness, as the TTM predicts. The ultimate aim of adopting a 
motivational interviewing approach is to increase individual’s readiness to change their 
maladaptive behaviour by endorsing a person centered approach to resolving their 
ambivalence about behaviour change and strengthening their own motivation and 
commitment to this change (Miller & Rollnick, 2012). Thus, it is thought that motivational 
interviewing increases individual’s readiness, which in turn facilitates adherence to chronic 
pain treatment. However, the second study of the current research project looked specifically 
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at the relationship between readiness and adherence and failed to find any evidence that 
readiness predicts adherence to pain self-management strategies.  
 
The finding that readiness at baseline was not related to adherence, even in the first week of 
the program may question the applicability of the TTM and motivational model of pain self-
management to chronic pain treatment. Although the principles of stages of change have been 
successfully applied to the field of addiction (Copeland, Frewen & Elkins, 2009; Marsh, Dale 
& Willis, 2007), it has received less support in other areas of behavior change, such as HIV-
risk behaviours (Burke et al., 2003). This suggests that the TTM may not be as relevant in 
some areas of health behaviour change as they are in others.  One of the major criticisms of 
the TTM is evidence against the notion that individuals go through various stages of change 
in a linear order (Littell & Girvin, 2002). For example, there is evidence that the same 
individual can move between the entire range of the stages of change within minutes and in a 
seemingly non-liner order (Rollnick, Mason & Butler, 1999). Importantly, the motivational 
model of pain self-management acknowledges and accounts for this evidence and describes 
readiness as being on a continuum as opposed to distinct changes (Jensen et al., 2003). 
Nevertheless, regardless of whether readiness is considered a stage or continuum, the core 
concepts of stages of change cannot be applied to the chronic pain field if it cannot be 
accurately measured. The current research project highlights the need for research in chronic 
pain that assesses the temporal aspect of current readiness measures, particularly with respect 
to the relationship between readiness over time and adherence to chronic pain treatment. 
Such a design is necessary before the relevance of TTM in pain can be dismissed. However, 
even if the proposed relationship between readiness and adherence exists over time, the 
current results expose the difficulty in identifying low levels of readiness so that they can be 
targeted by interventions in clinical settings.  
 117 
 
The findings of this study suggest that the current measure of readiness, at least when only 
administered at baseline, may not be a clinically useful measure as it potentially does not 
predict adherence to chronic pain treatment. The implication for clinical settings is that the 
findings do not support a ‘stage matched approach’ to chronic pain treatment. In stage 
matched treatment, individual's readiness is assessed and determines the best treatment 
approach. For example, individuals may receive motivational therapies if deemed 
precontemplative or contemplative of changing their pain related behaviour in an attempt to 
increase their readiness for completing active treatments such as cognitive behavioural pain 
self- management programs. Stage matched treatment is considered best practice in the drug 
and alcohol field (Copeland, Frewen & Elkins, 2009; Marshg, Dale & Willis, 2007), and has 
been suggested as a worthy area of investigation for chronic pain by several authors (e.g. 
Gersh, Arnold & Gibson, 2011; Jensen et al., 2003; Kerns & Habib, 2005). However, the 
study findings do not support this approach in chronic pain. In fact, results from this research 
suggest that even patients who appear unmotivated prior to treatment are equally likely to 
benefit as those who appear highly motivated. It is plausible that measures of readiness 
administered over a number of points in treatment would serve as a more sensitive measure 
of readiness and would highlight individuals who would benefit from therapies that aim to 
increase readiness to change pain related behaviour, although this has not been assessed. As 
outlined in chapter two of this thesis, meta-analytic data suggest motivational interviewing 
improved adherence to chronic pain treatment, with small to moderate effect sizes. However, 
without sensitive measures of individual’s readiness to adhere to self-management strategies, 
there is no way of determining who would benefit most from motivational approaches, such 
as motivational interviewing. More importantly, if motivation changes throughout the 
program and this change is associated with pain outcomes, this research has demonstrated 
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that the content of available programs appears to provide sufficient means of changing 
motivation at least for the half of the sample who were highly adherent. Therefore, the 
inclusion of motivational approaches may not be necessary in CBT programs. Whether 
motivational interviewing, however, would lead to higher rates of adherence to pain 
management and, as a result improve outcome, remains unknown. Furthermore, it is 
important to note that in this research projects meta-analysis, none of the included studies 
assessed functional outcomes in CBT-based programs. As such, any effort to routinely assess 
motivation and/or intervene to improve motivation in CBT-based chronic pain programs as 
part of routine care appears to be premature. In fact, since this research project found that 
early perceived benefit promotes adherence to pain self-management strategies in subsequent 
weeks and that motivation prior to the program did not impact on adherence, postponing well 
established evidence-based pain management treatment in order to apply motivational 
interviewing approaches may actually be counter-therapeutic as it would unnecessarily delay 
effective treatment. 
 
The meta-analysis from the current project assessed the impact of motivational interviewing 
on adherence to chronic pain treatment and pain outcomes, however there are a broad range 
of motivational interventions that have been applied to increase motivation in chronic pain. 
While there were clear advantages to limiting the meta-analysis to motivational interviewing 
approaches, there is still a need to further investigate the efficacy of other approaches and the 
mechanisms by which these interventions may impact on outcomes for chronic pain 
treatment. For example, Christiansen at al. (2010) demonstrated through a RCT that an 
intervention based on mental contrasting resulted in improvements in physical exercise and 
physical capacity. Mental contrasting is designed to strengthen an individual’s expectation of 
a better future by committing to a specific change in behaviour. It incorporates measuring and 
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discussing the participant’s confidence in changing their behaviours (i.e. self-efficacy) and 
the importance (expectancy/ perceived importance) of doing so (Christiensen et al., 2010). 
Research into the effectiveness of mental contrasting for chronic pain and its relevance to the 
motivational model of pain self-management may improve our understanding of the 
relationship between participant beliefs, motivation and adherence to chronic pain treatment. 
The current study’s finding that individual’s perceived benefit in engaging in pain self-
management strategies suggests that other interventions such as mental contrasting may 
improve adherence through changes in their beliefs about the importance or benefit of doing 
so. Similarly, these relationships could be explored with other motivational interventions that 
have been shown to improve either motivation to adopt pain self-management strategies or 
pain outcomes, such as message framing (Janke, Spring & Weaver, 2011), and motivational 
programs that incorporate education, oral contracts and reinforcing techniques for changes in 
behaviour (Friedrich et al., 1998; 2005). The findings from the current study suggest that 
interventions that increase individual’s perceived benefit in engaging in pain self-
management strategies may increase adherence to these strategies.  
 
4.3. Health psychology models and adherence 
The current research projects lack of support for the core tenants of both the TTM and the 
motivational model of pain self-management suggest that other health psychology models, 
such as the health belief model (Rosenstock, 2000), may be more appropriate for 
conceptualising our understanding of adherence to chronic pain treatment. In support for this 
claim, the only significant finding of the empirical study of this research project was that 
perceived benefit predicted adherence to pain self-management strategies. This is consistent 
with the concepts of the health belief model, social learning theory (Bandura, 1997) and 
social cognitive theory (Bandura, 1986), which stress the importance of an individual’s 
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expectations (such as immediate outcomes) of a chosen behaviour on their likelihood to 
perform such behaviour. Of the health psychology models, the health belief model has 
probably received the most attention. According to the health belief model (Rosenstock, 
2000), there are five main influences on an individual’s likelihood of adopting adaptive or 
prescribed health related behaviours: 1) perceived severity regarding the health condition and 
subsequent consequences for the individual; 2) perceived susceptibility of the individual to 
suffering from ill health; 3) internal or external cues to perform the behaviour, such as 
perceived internal symptom of illness or an external formal reminder to attend an 
appointment with a health professional; 4) perceived benefits of performing a specific 
behaviour; 5) perceived barriers to performing a specific behaviour. A recent meta-analysis 
demonstrated that of the five factors, perceived benefits and perceived barriers were reliably 
the best predictors of health related behaviour, though the effect is only small (Carpenter, 
2010). Regardless, the current research project supports the health belief model’s assertion 
that perceived benefit predicts adherence to self-management strategies in chronic pain and 
future research should aim to assess the other variables of the health belief model and their 
relationship with adherence.   
 
4.4. Early benefit in chronic pain treatment and the temporal process of change 
The finding that individual’s perceived benefit of using self-management strategies predicted 
adherence to these strategies in subsequent weeks, particularly early in treatment, not only 
illustrates the importance of individual’s attitudes and expectancies regarding the use of pain 
self-management strategies but it stresses the need for more research looking into the 
temporal nature of change and the process through which change occurs during chronic pain 
treatment. Although it is often assumed that change occurs in a gradual and linear fashion, 
there is increasing evidence that change during the course of a range of psychotherapeutic 
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interventions is actually rapid and non-linear. Critically, these sudden gains in treatment are 
shown to be responsible for treatment outcomes (Busch, Kanter, Landes & Kohlenberg, 
2006; Hayes, Laurenceau, Feldman, Strauss & Cardaciotto, 2007). For example, there is good 
evidence that among individuals who improve as a result of psychotherapy, improvements 
are not made gradually over a series of months, but are made rapidly in the first four weeks of 
treatment or even between single sessions in the first few weeks and then typically outcomes 
do not significantly improve further (Hayes, et al., 2007). This has been demonstrated across 
a range of psychotherapeutic modalities and presenting problems including depression (Ilardi 
& Craighead, 1994; Tang, Luborsky & Andrusyna, 2002), bulimia (Grilo, Masheb & Wilson, 
2006), panic (Penava, Otto, maki & Pollack, 1998) and problematic alcohol use (Breslin, 
Sobell, Sobell, Buchan & Cunningham, 1997). The finding that individual’s perceived benefit 
early in treatment predicted tangible behaviour change in the current study is strikingly 
similar to the literature around sudden gains. Since early gains in treatment have been shown 
to be one of the best predictors of treatment outcome, investigations into the mechanisms 
underlying individual’s perceived benefit in treatment deserve further attention. It is possible 
that perceived benefit early in treatment facilitates treatment outcomes through adherence or 
perhaps some other mechanism. Research is needed that looks at individual time course data 
as opposed to group means over time to better facilitate our understanding of how these 
changes may occur and the impact of these changes in chronic pain treatment (Barkham, 
Stiles & Shapiro, 1993).  
 
If rapid early responses to treatment predict outcomes, regardless of the form of 
psychotherapeutic intervention or presenting problem, then questions can be raised about the 
importance of active components of treatment, such as adherence to cognitive behavioural 
pain self-management strategies. Since many of the early gains during psychotherapeutic 
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interventions seem to occur prior to the dissemination of any formal active component of 
treatment, such as cognitive therapy for depression, some authors have proposed that non-
specific factors, such as the therapeutic alliance or participant expectancies are responsible 
for outcomes (Ilardi & Craighead, 1994). Consistent with this idea, meta-analytic research 
has demonstrated that the therapeutic alliance reliably accounts for small to moderate 
improvements in treatment outcome variables, regardless of the type of therapeutic alliance 
measure used, the time the alliance was assessed or the type of therapeutic alliance rater 
(Martin, Garske & Davis, 2000). Interestingly, the reported gains attributed to the therapeutic 
alliance are almost identical to the reported overall effectiveness of CBT for chronic pain 
(Eccleston, Morley & Williams, 2013). The present research project seems to refute this 
assertion that adherence to the active components of cognitive behavioural self-management 
strategies is responsible for treatment gains. While it was not within the scope of the research 
project to assess non-specific factors, it is possible that they may have contributed to the 
treatment outcomes.  
 
While the current project findings indicate that non-specific variables may have accounted 
for the treatment outcomes, such as the therapeutic alliance, it is important to consider the 
evidence in the broader context of chronic pain and other areas of research. Despite the null 
findings regarding adherence in the current project, there is fairly strong evidence regarding 
the impact of adherence to chronic pain treatment on outcomes in the same setting in larger 
samples (Nicholas et al., 2012: 2014). Moreover, the effects of non-specific factors, which 
are typically found to be small to medium in effect size (Martin, Garske & Davis, 2000), do 
not account for the medium to large effect sizes observed in the current treatment. Recent 
research assessing the impact of process measures on cognitive therapy for depression has 
demonstrated that symptom change early in treatment predicted the strength of the 
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therapeutic alliance (Strunk, Brotman & DeRubeis, 2010). Moreover, they found that 
adherence to cognitive therapy strategies was a significant predictor of symptom reduction. In 
other words, while the therapeutic alliance predicted treatment outcomes, the mechanism for 
change appeared to be adherence to treatment (cognitive strategies), which in turn led to 
symptom reduction and subsequently the strengthening of the therapeutic alliance. Taken 
together, the processes of change in chronic pain treatment and other areas where the 
principles of psychotherapeutic interventions are applied are relatively unclear. Part of the 
reason that there is no clear understanding of the processes of change in psychotherapeutic 
interventions is due to the design of research studies that typically collect group means 
throughout treatment rather than tracking the longitudinal process of change among 
individuals. There is a need for a systemic movement from research that compares group 
means to ascertain what intervention work to longitudinal research that assesses individual 
changes so that we can determine when, why and how change occurs (Hayes et al., 2007). 
Without this type of research, it is unlikely that a better understanding of the process of 
change during pain management programs will be identified.  
 
4.5. Measures of adherence in chronic pain research and clinical settings 
 
Although the primary goal of the current project was not to assess the relationship between 
adherence and outcomes, the current findings highlight the importance of valid and reliable 
measures of adherence in chronic pain. Not only is adherence an understudied area in chronic 
pain (Broekmans et al., 2009), there is a strong need to develop sound methods for measuring 
adherence, as the current methods available are less than ideal (Curran, Williams and Potts, 
2009; Nicholas et al., 2012: 2014). Importantly, the current research project has demonstrated 
that modifications to prior measures of adherence result in potentially significant differences 
in study findings and subsequent interpretations, possibly due to poor measurement validity. 
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As described earlier, the current research project employed a similar, though more thorough 
process of obtaining adherence compared with prior research in the same setting (Nicholas et 
al., 2012; 2014). Although the current study’s method of obtaining adherence was more 
thorough, it could be argued that the procedure was less valid as the treating clinician and not 
an independent researcher provided adherence scores. This may have contributed to the 
study’s inability to replicate the previous robust findings, which had been replicated. The 
differences between the measurement of adherence in the current study and prior studies in 
the same setting point to two key processes. First, prior research used a process of formally 
and frequently monitoring and recording participant adherence and correcting discrepancies 
between the therapists’ observation and participants’ recordings. Due to the number of 
specific self-management strategies that needed to be assessed and the increased number of 
occasions that adherence to these strategies were assessed, it was not feasible for the 
clinicians to undertake these formal steps in addition to their core responsibilities of running 
the program. Second, prior research used a process whereby overall adherence score were not 
given by treating therapists but an independent researcher rated adherence based on the 
formal recordings of adherence. These processes may be more valid or reliable in that they do 
not depend as much on therapist memory of participants’ adherence for a week long period as 
adherence is recorded daily, and they are not as subject to therapist bias as the final adherence 
scores are determined by an individual that is independent to the participants’ treatment. 
These processes may account for the differences in study findings.  
 
While it may be argued that Nicholas and colleagues have applied the most reliable methods 
of measuring adherence in chronic pain, it is still suboptimal. Current measures of adherence 
to chronic pain treatment have only focused on the adherence of participants to self-
management strategies but not the adherence of therapists to processes relevant to a 
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therapeutic intervention, often referred to as therapist fidelity. In other areas of 
psychotherapy, these two areas of adherence have been demonstrated to be unique and 
equally important. For example, DeRubeis and Feeley (1990) conducted a factor analysis of 
adherence to cognitive therapy for depression. They identified two forms of therapist 
adherence, concrete adherence and abstract adherence. According to the authors, concrete 
adherence refers to the process of disseminating active manual based strategies, such as how 
to challenge thoughts in cognitive therapy for depression or how to conduct exposure to fears 
in anxiety treatment. On the other hand, abstract adherence refers to the adherence to the 
wider processes that are known to be conducive to behaviour change, such as seeking 
increased knowledge of individual’s specific beliefs about their fear of re-injury in chronic 
pain or their perceptions of the therapy and their ideas about progress. Importantly, both of 
these forms of adherence have been shown to predict outcomes, such as reductions in 
depressive symptomatology in cognitive therapy for depression (Strunk, Brotman & 
DeRubeis, 2010). The findings of this body or research suggest that not only do adherence 
measures need to adopt thorough methods of obtaining participants adherence to active 
cognitive-behavioural strategies, methods of obtaining therapist related adherence also needs 
to be developed.  
 
The current study also demonstrated that it is more important to have a quality measure that 
only provides an overall estimate of adherence than a less valid and reliable measure that 
assesses a larger quantity of self-management strategies with greater specificity. Although 
adherence in the current study was not an independent predictor of pain outcomes or 
cognitive process measures, there was an association between overall adherence and 
improvements in disability and pain self-efficacy beliefs. In contrast, adherence to the 
specific self-management strategies did not predict pain outcomes or cognitive process 
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measures. From a theoretical perspective, the efficacy of multidisciplinary pain programs that 
are based on cognitive-behavioural pain self-management strategies is likely a result of 
individual’s adopting a combination of adaptive self-management strategies, not one 
particular strategy in isolation. As a result, adherence to a number of strategies as opposed to 
any one particular strategy should be a better predictor of pain outcomes. It would be 
interesting to compare the reliability and validity of adherence to specific self-management 
strategies with overall measures and pain outcomes using a more reliable process to obtain 
adherence, such as the procedure used by Nicholas et al. (2012; 2014). Not only would this 
research substantiate the above-mentioned hypothesis, it may point toward the types of self-
management strategies that are most critical for predicting pain outcomes.  
 
4.6. Limitations and directions for future research 
 
Although the limitations of each study in this research project have already been outlined, 
this project has also identified boarder limitations in this area of research that should be 
considered when interpreting the project’s findings and they highlight directions for future 
research. 
 
4.6.1. Small evidence base 
The current project has highlighted the scarcity of research into motivation and adherence in 
chronic pain, in effect limiting the strength of any conclusions that can be drawn from this 
project. As discussed in the second chapter, one of the major limitations of the meta-analysis 
was the small number of RCTs that assessed motivational interviewing approaches for 
chronic pain treatments. It is particularly concerning that there were not enough studies to 
assess the impact of motivational interviewing approaches on physical functioning, as 
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reducing disability and improving physical function despite pain is generally the primary 
outcome of chronic pain treatments. Furthermore, as outlined in chapter one, CBT has the 
strongest evidence base with regard to the treatment of chronic pain, yet none of the included 
studies in the meta-analysis were based on CBT approaches. In order to draw firm 
conclusions about the effectiveness of motivational interviewing approaches on chronic pain 
there is a need for further RCT’s that assess motivational interviewing approaches and their 
impact on chronic pain treatments, particularly treatments with strong evidence bases such as 
CBT-based pain management programs. To date, there is only one trial currently underway 
(Mertens et al., 2013). It is just as important that this future body of research assesses key 
pain outcomes such as physical functioning. For example, there is a need for a RCT that 
assesses the impact of motivational interviewing approaches on adherence and subsequent 
outcomes, such as physical function, following CBT-based pain management programs. 
 
The empirical study in this research project was the first study to assess the relationship 
between readiness to adopt pain self-management strategies and adherence to these strategies. 
While this is one of the strengths of the current research project, it emphasises the lack of 
evidence for key theoretical models, such as the motivational model of pain self-management 
and the transtheoretical model in chronic pain (Jensen, Nielson & Kerns, 2003). The 
implication of this limitation is discussed below. 
 
 
4.6.2. Validation of key theoretical models  
The findings of the current project have not only demonstrated the lack of research 
supporting key theoretical models, such as the motivational model of pain self-management 
and the transtheoretical model, but the results do not support the key tenants of these models. 
The second chapter of this research project demonstrated that motivational interviewing 
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approaches likely improve adherence to chronic pain treatment. One could argue that these 
findings are consistent with the motivational model of pain self-management and the 
transtheoretical model. For example, it could be argued that motivational interviewing 
approaches aim to increase individuals’ perceived importance of self-management behaviours 
and their readiness to adopt these behaviours, as specified in the motivational model of pain 
self-management. Moreover, motivational interviewing approaches are thought to help 
resolve individuals’ ambivalence in order to move individuals into a stage of action. 
However, none of the studies included in the review measured stages of change. And indeed, 
recently Miller (2009) has begun to distance motivational interviewing from the TTM, 
describing them as “kissing cousins” and highlighting that motivational interviewing was 
never based on the TTM. Hence, it is not necessarily inconsistent to say that motivational 
interviewing may be effective in pain, even if the motivational theoretical models are not 
valid in relation to pain. Further, as already mentioned, it is important to note that none of the 
included studies in the meta-analysis assessed adherence to CBT-based pain self-
management strategies, the very strategies outlined in the motivational model of pain self-
management. The empirical study of this research project was designed to validate key 
aspects of the motivational model of pain self-management by assessing the relationships 
between the various components. The findings from this study were quite clear in that 
readiness to change was not associated with adherence one week later. This does not fit with 
either the motivational model of pain self-management or the transtheoretical model and is a 
major problem for both theories when applied to chronic pain treatment. Importantly, these 
findings were based on a successful evidence based CBT-program that promoted the very 
self-management behaviours outlined in the motivational model of pain self-management. In 
other words, motivational interviewing approaches appear to increase adherence, even though 
there is no evidence that this is through increasing readiness to change. Interestingly, the 
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findings from this research project suggest that individual’s perceived benefit, which could be 
considered to align with the motivational model of pain self-managements ‘perceived 
importance’ construct, predicts adherence. In order to increase our understanding of the 
potential of motivational approaches in chronic pain, there is a need for research that aims to 
determine not just if motivational interviewing works but what are the mechanisms of 
change.  
 
 
4.6.3. Process driven research 
In order to increase our understanding of how to improve current chronic pain treatment, 
there is a need to validate key theoretical models, such as the motivational model of pain self-
management, and this requires process driven research that assesses the various components 
of these models in isolation. The current research project has demonstrated that there is a 
need to better understand a number of key processes, which should form the basis of 
investigation of future research. First, future research needs to determine whether readiness to 
adopt pain self-management strategies leads to adherence to these strategies. Both the 
motivational model of pain self-management and the transtheoretical model of behaviour 
change hold the assumption that readiness to adopt self-management strategies leads to the 
adoption or adherence to these strategies. Although this was not supported in this projects 
empirical study, there were limitations with the study’s procedure for measuring adherence 
and motivation and this may have impacted on the study findings. As outlined in the 
discussion of chapter three, one explanation for the null findings may be due to the fact that 
readiness may be a dynamic construct that changes rapidly. It is plausible that measures of 
readiness administered over a number of stages in treatment would serve as a more sensitive 
measure of readiness and would highlight individuals who would benefit from therapies that 
aim to increase readiness to change pain related behaviour, though this has not been assessed. 
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Periodically measuring readiness and adherence will expand our knowledge of the 
relationship between these two key processes that are at the centre of key motivational 
models in chronic pain.  
 
Second, future research needs to determine whether adherence translates to key pain 
outcomes and the mechanisms through which this process may occur. Although prior 
research (Nicholas et al., 2012; 2014) has replicated the finding that adherence to pain self-
management strategies in a CBT-based pain management program independently predicts 
key pain outcomes, the findings of the current research project questions the importance of 
adherence. The current projects’ meta-analysis found that motivational interviewing 
significantly increased adherence to prescribed chronic pain treatment and improvements in 
pain severity. However, it was not possible to determine whether improvements in pain 
outcomes were due to adherence. Critically, the current projects empirical study failed to 
replicate the finding that adherence to pain self-management strategies predicted pain 
outcomes despite conducting the research in the same setting. Future research is needed that 
manipulates individual’s levels of adherence to pain self-management strategies so that the 
effect of adherence on pain outcomes can be determined. For example, one could conduct a 
study whereby individuals in a CBT-based pain management program are assigned to groups 
that undergo varying levels of adherence/ exposure to the use of pain self-management 
strategies. Furthermore, one could measure adherence regularly throughout the program as 
well as pain outcomes, such as physical functioning, so that the relationship between the two 
can be discerned.  
 
Third, the current research project’s failure to support key processes, as outline by the 
motivational model of pain self-management, the transtheoretical model and the findings by 
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Nicholas et al. (2012; 2014), highlight the need to better understand the processes by which 
other motivational interventions facilitate outcomes. Although the current projects meta-
analysis found that motivational interviewing approaches likely lead to short term increases 
in adherence to prescribed chronic pain treatments, there may be other motivational 
approaches that also lead to short term increases in adherence, such as mental contrasting 
(Christiansen et al., 2010) and compliance counselling (Jamison et al., 2010). It would be 
interesting to compare the impact of motivational interviewing approaches and these other 
motivational interventions on adherence and pain outcomes over time.  
 
Finally, in line with the recommendations of Morley, Williams and Eccleston (2013), there is 
a clear need to assess the unique processes of change in CBT-based treatments of chronic 
pain. The current research projects empirical study found that readiness to adopt pain self-
management strategies at baseline was not associated with adherence at the end of any week 
of the CBT-based pain-management program. In other words, individuals’ readiness at the 
start of the program had no bearing on the extent to which they adhered to pain self-
management strategies throughout the program. These findings suggest that there may be 
other processes inherent in the CBT program that facilitate adherence but without research 
investigating why these programs are effective there is no way of furthering our 
understanding of chronic pain treatment and how to go about improving existing treatment. 
Research is needed that manipulates and assess all the known mediators and moderators of 
change throughout treatment as opposed to studies that assess these key variables at the start 
and end of treatment. This type of investigation would allow for a greater understanding of 
the causal mechanisms associated with adherence to treatment and treatment outcomes as 
opposed to determining associations between variables. Information on the causal 
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mechanisms of adherence and the impact on treatment outcomes would provide rich 
information on how to improve current treatment efficacy.   
 
4.6.4. Generalisability of project results 
It is important to consider the limitations in generalising the research projects findings. First, 
the current research projects’ meta-analysis included studies that assessed a range of chronic 
pain treatment for a variety of chronic pain conditions and each study evaluated different 
outcome measures. As a result, it is possible that the findings from this meta-analysis may not 
be representative of the likely impact of motivational interviewing approaches in all chronic 
pain treatments. As mentioned previously, none of the included studies assessed the impact of 
motivational interviewing approaches on gold standard CBT-based pain management 
programs and as such, the efficacy of motivational interviewing approaches in these 
programs is unknown. An RCT that assesses the impact of motivational interviewing on 
adherence and pain outcomes in a CBT-based pain management program would demonstrate 
the generalisability of these meta-analytic findings.  
 
It is also important to recognise that in the current research projects’ empirical study, 
individuals were volunteering to undergo an intensive three-week program that for most 
involved living away from their home, family and friends. It could be argued that this group 
of individuals are unrepresentative of individuals undergoing chronic pain treatment, 
particularly with regard to their motivation to adopt pain self-management strategies. The 
inherent motivation of this group of individuals to complete the pain management program 
may have impacted on the empirical study’s failure to find an association between motivation 
and adherence and future research is needed to investigate the association between readiness 
and adherence in different treatment settings for chronic pain. In fact, it could be argued that 
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this is a broader limitation of this area of research as it is hard to imagine many individuals 
are precontemplative in their motivation to adhere to treatment when they are treatment 
seeking in the first place. It would be beneficial to assess how readiness and adherence are 
related in different settings, including treatment settings where individuals are less likely to 
be motivated to adhere to treatment.  
 
4.7. Conclusion 
 
This research project was the first body of research to investigate the theoretical and clinical 
application of readiness constructs and motivational interventions with adherence in chronic 
pain treatment. The meta-analysis and systematic review demonstrated the potential for 
motivational interventions to improve adherence to chronic pain treatment, though the effect 
of these interventions on pain outcomes is less clear. In an attempt to understand the 
mechanisms through which motivational interventions may impact on adherence, the 
empirical study failed to find any meaningful associations between readiness and adherence 
and there is a clear need for process oriented research in order to identify the causal 
mechanisms of change. These initial findings do not support the motivational model of pain 
self-management or the transtheoretical model of behaviour change. Interestingly, 
participants perceived benefits of using self-management strategies predicted adherence in 
subsequent weeks, particularly early in treatment. The importance of perceived benefit and 
the null findings regarding readiness and adherence suggest that other health psychology 
models, such as the health belief model may be more suitable for understanding how to 
improve adherence to chronic pain treatment. Finally, the inability to replicate the robust 
finding that adherence predicts pain outcomes, questions the importance of adherence in 
chronic pain treatment and the need for standardised and valid adherence measures. This 
research project has provided the basis for further research to uncover the factors that 
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influence adherence and the impact of adherence to chronic pain treatment on pain outcomes. 
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PARTICIPANT INFORMATION STATEMENT  
 
(1) What is the study about? 
 
The purpose of this study is to examine the reasons that people with chronic pain adhere to pain self-
management strategies. This participant Information Sheet tells you about the research project. 
Knowing what is involved will help you decide if you want to take part in this research. Please read this 
information carefully. Ask questions about anything that you don’t understand or want to know more 
about. Before deciding whether or not to take part, you might want to talk about it with a relative, friend 
or local doctor.  
 
(2) Who is carrying out the study? 
 
The study is being conducted by Dion Alperstein and will form the basis for the degree of Master of 
Science at The University of Sydney under the supervision of Professor Louise Sharpe and Professor 
Michael Nicholas, Royal North Shore Hospital. 
 
(3) What does the study involve? 
 
It is standard practice that all participants in the ADAPT program fill out questionnaires about their 
thoughts, feelings and behaviours. This study will require you to provide consent for the researcher to 
access this information that is already collected.  
 
(4) How much time will the study take? 
 
As a participant of the ADAPT program, this study will not take any additional time. All data is already 
routinely collected as part of the assessment and on going evaluation of the ADAPT program.  
 
(5) Can I withdraw from the study? 
 
Being in this study is completely voluntary - you are not under any obligation to take part and - if you 
do decide to participate - you can withdraw at any time without affecting your relationship with The 
University of Sydney School of Psychology, the Pain Management Research Institute, or Royal North 
Shore Hospital.  
 
(6) Will anyone else know the results? 
 
All aspects of the study, including results, will be strictly confidential and only the researchers will have 
access to information from your medical record. A report of the study may be submitted for publication, 
but individual participants will not be identifiable in such a report. 
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Benefit	Rating	Form	-	Week	1	
	
 
Patient name__________________________________ Group #____________________________________ 
 
Instructions. Please circle the number that best describes the benefit you received from using the self-management 
strategy this week.  
  
Pacing 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Goal setting 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Thought Management 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Desensitization 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Stretching 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
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Benefit	Rating	Form	-	Week	2	
	
	
 
Patient name__________________________________ Group #____________________________________ 
 
Instructions. Please circle the number that best describes the benefit you received from using the self-management 
strategy this week.  
  
Pacing 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Goal setting 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Thought Management 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Desensitization 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Stretching 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
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Benefit	Rating	Form	-	Week	3	
	
	
 
Patient name__________________________________ Group #____________________________________ 
 
Instructions. Please circle the number that best describes the benefit you received from using the self-management 
strategy this week.  
  
Pacing 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Goal setting 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Thought Management 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Desensitization 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
 
 
Stretching 
0  = ‘I did not benefit from using the strategy’  
1  = ‘I am unsure that I benefited from using the strategy’  
2  = ‘I benefited from using the strategy’ 
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Staff - Adherence Rating Form  
 
 
Patient name__________________________________ Group #____________________________________ 
 
Please score the patient’s weekly adherence to each self-management strategy using the following scale: 
0 = ‘not using the strategy at all’ 
1 = ‘using it inconsistently’  
2 = ‘using it consistently’ 
 
Pacing: 
Score 
Week 1:                             0     1    2 
Week 2:                             0     1    2 
Week 3:                             0     1    2 
 
Goal setting: 
Score 
Week 1:                             0     1    2 
Week 2:                             0     1    2 
Week 3:                             0     1    2 
 
Thought management: 
Score 
Week 1:                             0     1    2 
Week 2:                             0     1    2 
Week 3:                             0     1    2 
 
Desensitization: 
Score 
Week 1:                             0     1    2 
Week 2:                             0     1    2 
Week 3:                             0     1    2 
 
Stretching: 
Score 
Week 1:                             0     1    2 
Week 2:                             0     1    2 
Week 3:                             0     1    2 
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Appendix D: 
 
Statistical output for meta-analysis and empirical study  
 
(See USB at back) 
 
 
 
 
 
 
 
 
 
 
 
 
 
